| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 6.69e-07 | 18 | 196 | 5 | GO:0008569 | |
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | 1.49e-06 | 37 | 196 | 6 | GO:0004190 | |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | 1.76e-06 | 38 | 196 | 6 | GO:0070001 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 7.08e-06 | 28 | 196 | 5 | GO:0051959 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 2.17e-05 | 118 | 196 | 8 | GO:0003774 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 2.92e-05 | 37 | 196 | 5 | GO:0045505 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | MYO1E IFIH1 ATP13A3 DYNC1H1 RAD54L DNAH3 DNAH10 DNAH2 HELQ DNAH7 DHX30 EIF4A2 ATP5F1A TDRD12 | 1.22e-04 | 441 | 196 | 14 | GO:0016887 |
| GeneOntologyMolecularFunction | ATP-dependent activity | MYO1E MYO5C IFIH1 ATP13A3 DYNC1H1 RAD54L DNAH3 DNAH10 DNAH2 HELQ DNAH7 DHX30 EIF4A2 MYO1F HLTF ATP5F1A TDRD12 | 1.23e-04 | 614 | 196 | 17 | GO:0140657 |
| GeneOntologyMolecularFunction | histone H2AXS139 kinase activity | 2.86e-04 | 3 | 196 | 2 | GO:0035979 | |
| GeneOntologyMolecularFunction | nuclear receptor activity | 3.05e-04 | 60 | 196 | 5 | GO:0004879 | |
| GeneOntologyMolecularFunction | ligand-activated transcription factor activity | 3.30e-04 | 61 | 196 | 5 | GO:0098531 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 6.25e-04 | 70 | 196 | 5 | GO:0003777 | |
| GeneOntologyMolecularFunction | proteasome binding | 9.39e-04 | 20 | 196 | 3 | GO:0070628 | |
| GeneOntologyMolecularFunction | histone H2AX kinase activity | 9.40e-04 | 5 | 196 | 2 | GO:0141003 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | HK2 ATR ERVK-7 POLA2 TYK2 PARP6 GK BTK MAP3K9 MAP3K15 PGS1 GNPTAB POLR2E POLR2H TEP1 LATS2 CSNK1A1 PRKCD ATM IPMK | 9.49e-04 | 938 | 196 | 20 | GO:0016772 |
| GeneOntologyMolecularFunction | helicase activity | 9.66e-04 | 158 | 196 | 7 | GO:0004386 | |
| GeneOntologyCellularComponent | inner dynein arm | 1.57e-06 | 10 | 198 | 4 | GO:0036156 | |
| GeneOntologyCellularComponent | axonemal dynein complex | 3.30e-06 | 25 | 198 | 5 | GO:0005858 | |
| GeneOntologyCellularComponent | dynein complex | 1.18e-05 | 54 | 198 | 6 | GO:0030286 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | ATR NUP210L ZNF217 RBM48 POLA2 CXXC1 STAT1 STAT3 EFTUD2 BRCA1 PER2 INTS2 KMT2A SUPT3H MMS22L IPO7 ARID4A POLR2E POLR2H BCCIP XPO4 E2F3 HEATR1 TEP1 CSNK1A1 RFXANK HLTF INTS4 CDC20 ATP5F1A | 1.64e-05 | 1377 | 198 | 30 | GO:0140513 |
| Domain | HEAT | 1.26e-09 | 48 | 192 | 9 | PF02985 | |
| Domain | HEAT_REPEAT | ATR NCAPG2 PSME4 GCN1 CLASP1 TNPO2 HEATR1 ECPAS PPP2R1B INTS4 | 2.42e-09 | 70 | 192 | 10 | PS50077 |
| Domain | HEAT | 7.33e-09 | 58 | 192 | 9 | IPR000357 | |
| Domain | - | ATR NCAPG2 PSME4 GCN1 IPO7 CLASP1 TNPO2 XPO4 HEATR1 ECPAS WDFY4 PPP2R1B INTS4 PUM1 TNPO3 | 1.01e-08 | 222 | 192 | 15 | 1.25.10.10 |
| Domain | ARM-type_fold | ATR NCAPG2 PSME4 GCN1 IPO7 CLASP1 TNPO2 UBR4 XPO4 HEATR1 ECPAS WDFY4 VIRMA PPP2R1B INTS4 ATM PUM1 TNPO3 | 1.44e-08 | 339 | 192 | 18 | IPR016024 |
| Domain | ARM-like | ATR NCAPG2 PSME4 GCN1 IPO7 CLASP1 TNPO2 XPO4 HEATR1 ECPAS WDFY4 PPP2R1B CEP70 INTS4 PUM1 TNPO3 | 2.06e-08 | 270 | 192 | 16 | IPR011989 |
| Domain | Dynein_heavy_chain_D4_dom | 2.02e-07 | 14 | 192 | 5 | IPR024317 | |
| Domain | Dynein_HC_stalk | 2.02e-07 | 14 | 192 | 5 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 2.02e-07 | 14 | 192 | 5 | IPR013602 | |
| Domain | DHC_N2 | 2.02e-07 | 14 | 192 | 5 | PF08393 | |
| Domain | MT | 2.02e-07 | 14 | 192 | 5 | PF12777 | |
| Domain | AAA_8 | 2.02e-07 | 14 | 192 | 5 | PF12780 | |
| Domain | DHC_fam | 3.01e-07 | 15 | 192 | 5 | IPR026983 | |
| Domain | Dynein_heavy | 3.01e-07 | 15 | 192 | 5 | PF03028 | |
| Domain | Dynein_heavy_dom | 3.01e-07 | 15 | 192 | 5 | IPR004273 | |
| Domain | ATPase_dyneun-rel_AAA | 1.00e-05 | 14 | 192 | 4 | IPR011704 | |
| Domain | AAA_5 | 1.00e-05 | 14 | 192 | 4 | PF07728 | |
| Domain | HEAT_type_2 | 2.32e-05 | 17 | 192 | 4 | IPR021133 | |
| Domain | DHC_N1 | 5.77e-05 | 8 | 192 | 3 | PF08385 | |
| Domain | Dynein_heavy_dom-1 | 5.77e-05 | 8 | 192 | 3 | IPR013594 | |
| Domain | Cytoplasmic_FMR1-int | 1.05e-04 | 2 | 192 | 2 | IPR008081 | |
| Domain | Ecm29/Gcn1 | 1.05e-04 | 2 | 192 | 2 | IPR026827 | |
| Domain | FragX_IP | 1.05e-04 | 2 | 192 | 2 | PF05994 | |
| Domain | VPS13 | 3.13e-04 | 3 | 192 | 2 | IPR026847 | |
| Domain | VPS13_mid_rpt | 3.13e-04 | 3 | 192 | 2 | PF16910 | |
| Domain | VPS13 | 3.13e-04 | 3 | 192 | 2 | PF16908 | |
| Domain | VPS13_N2 | 3.13e-04 | 3 | 192 | 2 | IPR031646 | |
| Domain | VPS13_mid_rpt | 3.13e-04 | 3 | 192 | 2 | IPR031642 | |
| Domain | SHR-BD | 6.22e-04 | 4 | 192 | 2 | IPR009543 | |
| Domain | Carboxyl_trans | 6.22e-04 | 4 | 192 | 2 | PF01039 | |
| Domain | DUF1394 | 6.22e-04 | 4 | 192 | 2 | IPR009828 | |
| Domain | COA_CT_CTER | 6.22e-04 | 4 | 192 | 2 | PS50989 | |
| Domain | COA_CT_NTER | 6.22e-04 | 4 | 192 | 2 | PS50980 | |
| Domain | DUF1394 | 6.22e-04 | 4 | 192 | 2 | PF07159 | |
| Domain | VPS13_C | 6.22e-04 | 4 | 192 | 2 | PF16909 | |
| Domain | COA_CT_N | 6.22e-04 | 4 | 192 | 2 | IPR011762 | |
| Domain | COA_CT_C | 6.22e-04 | 4 | 192 | 2 | IPR011763 | |
| Domain | VPS13_C | 6.22e-04 | 4 | 192 | 2 | IPR031645 | |
| Domain | SHR-BD | 6.22e-04 | 4 | 192 | 2 | PF06650 | |
| Domain | Carboxyl_trans | 6.22e-04 | 4 | 192 | 2 | IPR000022 | |
| Domain | - | MYO1E EFTUD2 IFIH1 SEPTIN8 DYNC1H1 RAD54L DNAH3 DNAH10 DNAH2 TEP1 HELQ DNAH7 DHX30 EIF4A2 MYO1F HLTF ATP5F1A TDRD12 | 7.09e-04 | 746 | 192 | 18 | 3.40.50.300 |
| Domain | Helicase_C | 8.35e-04 | 107 | 192 | 6 | PF00271 | |
| Domain | HELICc | 8.35e-04 | 107 | 192 | 6 | SM00490 | |
| Domain | Helicase_C | 8.77e-04 | 108 | 192 | 6 | IPR001650 | |
| Domain | HELICASE_CTER | 9.20e-04 | 109 | 192 | 6 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 9.20e-04 | 109 | 192 | 6 | PS51192 | |
| Domain | DEXDc | 9.20e-04 | 109 | 192 | 6 | SM00487 | |
| Domain | Helicase_ATP-bd | 9.65e-04 | 110 | 192 | 6 | IPR014001 | |
| Domain | Autophagy-rel_C | 1.03e-03 | 5 | 192 | 2 | IPR015412 | |
| Domain | ATG_C | 1.03e-03 | 5 | 192 | 2 | PF09333 | |
| Domain | FATC | 1.03e-03 | 5 | 192 | 2 | PF02260 | |
| Domain | P-loop_NTPase | MYO1E MYO5C EFTUD2 IFIH1 SEPTIN8 DYNC1H1 RAD54L DNAH3 DNAH10 DNAH2 TEP1 HELQ DNAH7 DHX30 EIF4A2 MYO1F HLTF ATP5F1A TDRD12 | 1.21e-03 | 848 | 192 | 19 | IPR027417 |
| Domain | Znf_hrmn_rcpt | 1.26e-03 | 46 | 192 | 4 | IPR001628 | |
| Domain | NUCLEAR_REC_DBD_2 | 1.26e-03 | 46 | 192 | 4 | PS51030 | |
| Domain | NUCLEAR_REC_DBD_1 | 1.26e-03 | 46 | 192 | 4 | PS00031 | |
| Domain | ZnF_C4 | 1.26e-03 | 46 | 192 | 4 | SM00399 | |
| Domain | zf-C4 | 1.26e-03 | 46 | 192 | 4 | PF00105 | |
| Domain | Nuclear_hrmn_rcpt | 1.26e-03 | 46 | 192 | 4 | IPR001723 | |
| Domain | Nucl_hrmn_rcpt_lig-bd | 1.48e-03 | 48 | 192 | 4 | IPR000536 | |
| Domain | HOLI | 1.48e-03 | 48 | 192 | 4 | SM00430 | |
| Domain | Hormone_recep | 1.48e-03 | 48 | 192 | 4 | PF00104 | |
| Domain | FAT | 1.53e-03 | 6 | 192 | 2 | PS51189 | |
| Domain | FATC | 1.53e-03 | 6 | 192 | 2 | PS51190 | |
| Domain | FAT | 1.53e-03 | 6 | 192 | 2 | PF02259 | |
| Domain | PIK-rel_kinase_FAT | 1.53e-03 | 6 | 192 | 2 | IPR003151 | |
| Domain | FATC_dom | 1.53e-03 | 6 | 192 | 2 | IPR003152 | |
| Domain | PIK_FAT | 1.53e-03 | 6 | 192 | 2 | IPR014009 | |
| Domain | FATC | 1.53e-03 | 6 | 192 | 2 | SM01343 | |
| Domain | STAT_TF_DNA-bd_sub | 2.13e-03 | 7 | 192 | 2 | IPR012345 | |
| Domain | STAT | 2.13e-03 | 7 | 192 | 2 | IPR001217 | |
| Domain | STAT_int | 2.13e-03 | 7 | 192 | 2 | SM00964 | |
| Domain | STAT_TF_DNA-bd | 2.13e-03 | 7 | 192 | 2 | IPR013801 | |
| Domain | STAT_bind | 2.13e-03 | 7 | 192 | 2 | PF02864 | |
| Domain | STAT_int | 2.13e-03 | 7 | 192 | 2 | PF02865 | |
| Domain | - | 2.13e-03 | 7 | 192 | 2 | 1.10.532.10 | |
| Domain | STAT_alpha | 2.13e-03 | 7 | 192 | 2 | PF01017 | |
| Domain | - | 2.13e-03 | 7 | 192 | 2 | 1.20.1050.20 | |
| Domain | STAT_TF_prot_interaction | 2.13e-03 | 7 | 192 | 2 | IPR013799 | |
| Domain | STAT_TF_coiled-coil | 2.13e-03 | 7 | 192 | 2 | IPR015988 | |
| Domain | - | 2.13e-03 | 7 | 192 | 2 | 2.60.40.630 | |
| Domain | Myosin_TH1 | 2.13e-03 | 7 | 192 | 2 | PF06017 | |
| Domain | Myosin_TH1 | 2.13e-03 | 7 | 192 | 2 | IPR010926 | |
| Domain | TH1 | 2.13e-03 | 7 | 192 | 2 | PS51757 | |
| Domain | STAT_TF_alpha | 2.83e-03 | 8 | 192 | 2 | IPR013800 | |
| Domain | Chorein_N | 2.83e-03 | 8 | 192 | 2 | PF12624 | |
| Domain | K_chnl_volt-dep_Kv1 | 2.83e-03 | 8 | 192 | 2 | IPR003972 | |
| Domain | VPS13_N | 2.83e-03 | 8 | 192 | 2 | IPR026854 | |
| Domain | Znf_NHR/GATA | 2.98e-03 | 58 | 192 | 4 | IPR013088 | |
| Domain | Tudor | 3.54e-03 | 30 | 192 | 3 | IPR002999 | |
| Domain | Serpin_CS | 4.26e-03 | 32 | 192 | 3 | IPR023795 | |
| Domain | ZF_CXXC | 5.44e-03 | 11 | 192 | 2 | PS51058 | |
| Domain | Znf_CXXC | 5.44e-03 | 11 | 192 | 2 | IPR002857 | |
| Domain | zf-CXXC | 5.44e-03 | 11 | 192 | 2 | PF02008 | |
| Domain | Cation/H_exchanger_CPA1 | 5.44e-03 | 11 | 192 | 2 | IPR018422 | |
| Domain | Serpin_dom | 5.95e-03 | 36 | 192 | 3 | IPR023796 | |
| Domain | IQ | 6.15e-03 | 71 | 192 | 4 | PF00612 | |
| Domain | SERPIN | 6.43e-03 | 37 | 192 | 3 | PS00284 | |
| Domain | SERPIN | 6.43e-03 | 37 | 192 | 3 | SM00093 | |
| Domain | FAD-dep_OxRdtase | 6.48e-03 | 12 | 192 | 2 | IPR006076 | |
| Domain | DAO | 6.48e-03 | 12 | 192 | 2 | PF01266 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | ACACA STXBP4 SIPA1L3 STAT3 PTPN3 XRN1 MAP3K9 KMT2A MACIR ARAP2 CLASP1 RALGPS2 VIRMA DNAH7 CARD8 CSNK1A1 RBM7 EXO1 CRYBG3 CDC20 PUM1 DEPDC1B TNPO3 | 1.45e-09 | 861 | 202 | 23 | 36931259 |
| Pubmed | Quantitation of HERV-K env gene expression and splicing in human breast cancer. | 5.50e-09 | 5 | 202 | 4 | 12629516 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | HK2 ACACA CXXC1 NCAPG2 STAT1 EFTUD2 SERPINB6 CYFIP1 PSME4 A2ML1 XRN1 GCN1 DYNC1H1 ANKFY1 IPO7 DSG1 UBR4 POLR2E POLR2H HEATR1 DHX30 TKT RBM7 HLTF PRKCD CDC20 PUM1 ATP5F1A | 6.13e-09 | 1353 | 202 | 28 | 29467282 |
| Pubmed | ATR NCAPG2 STAT1 STAT3 ALDH3A2 GCN1 IPO7 TNPO2 XPO4 PPP2R1B TNPO3 | 1.15e-08 | 183 | 202 | 11 | 23956138 | |
| Pubmed | 1.21e-08 | 14 | 202 | 5 | 9373155 | ||
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | FOXK2 STXBP4 NCAPG2 TYK2 PTPN3 CYFIP1 PTPRM AGL XRN1 ALDH3A2 GCN1 MTCH2 IPO7 CLASP1 UBR4 XPO4 HEATR1 ECPAS PPP2R1B CSNK1A1 TKT ESPL1 TNPO3 | 1.45e-08 | 974 | 202 | 23 | 28675297 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | HK2 ACACA ATR VPS13C STAT1 EFTUD2 CYFIP1 ALDH3A2 GCN1 MTCH2 DYNC1H1 ANKFY1 IPO7 DNAH10 DSG1 UBR4 BCCIP HEATR1 ECPAS CYFIP2 DHX30 TKT PRKCD ATM PUM1 NNT ATP5F1A | 7.14e-08 | 1425 | 202 | 27 | 30948266 |
| Pubmed | HK2 ACACA L2HGDH SERPINB6 AGL XRN1 GCN1 DYNC1H1 ANKFY1 UBR4 POLR2E POLR2H DHX30 TKT PUM1 NNT | 1.11e-07 | 534 | 202 | 16 | 35032548 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | ACACA ATR ESRRA ZNF217 POLA2 EFTUD2 ZBTB40 KMT2A CLASP1 ARID4A ECPAS VIRMA TKT RBM7 EXO1 PRKCD ELF1 ATM ESPL1 | 1.55e-07 | 774 | 202 | 19 | 15302935 |
| Pubmed | A subset of ATM- and ATR-dependent phosphorylation events requires the BRCA1 protein. | 1.93e-07 | 3 | 202 | 3 | 12773400 | |
| Pubmed | Functional interactions between BRCA1 and the checkpoint kinase ATR during genotoxic stress. | 1.93e-07 | 3 | 202 | 3 | 11114888 | |
| Pubmed | 1.93e-07 | 3 | 202 | 3 | 34301763 | ||
| Pubmed | 1.93e-07 | 3 | 202 | 3 | 27625305 | ||
| Pubmed | 1.93e-07 | 3 | 202 | 3 | 11278964 | ||
| Pubmed | L2HGDH POLA2 STAT3 EFTUD2 CYFIP1 ALDH3A2 DYNC1H1 IPO7 TNPO2 ECPAS HLTF INTS4 PUM1 NNT TNPO3 ATP5F1A | 2.10e-07 | 560 | 202 | 16 | 35241646 | |
| Pubmed | EFTUD2 GK INTS2 VPS13A ALDH3A2 GCN1 MTCH2 MMS22L IPO7 UBR4 XPO4 HEATR1 ECPAS TMEM38B TMED8 TNPO3 ATP5F1A | 3.48e-07 | 657 | 202 | 17 | 36180527 | |
| Pubmed | 3.53e-07 | 11 | 202 | 4 | 7543024 | ||
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | HK2 ACACA L2HGDH NCAPG2 STAT1 EFTUD2 CYFIP1 PSME4 AGL ALDH3A2 GCN1 DYNC1H1 IPO7 DSG1 UBR4 POLR2E POLR2H BCCIP DHX30 PPP2R1B HLTF EXO1 PUM1 ATP5F1A | 3.54e-07 | 1257 | 202 | 24 | 37317656 |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | ATR NFU1 PTPN3 CYFIP1 INTS2 BTK MAP3K9 KMT2A MTCH2 ANKFY1 CLASP1 POLR2E POLR2H CYFIP2 LATS2 CSNK1A1 PRKCD CDC20 ESPL1 IPMK | 4.16e-07 | 910 | 202 | 20 | 36736316 |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | ACACA STAT1 EFTUD2 SEPTIN8 PTPN3 GCN1 DYNC1H1 MMS22L DSG1 CLASP1 TNPO2 UBR4 POLR2H RALGPS2 BCCIP XPO4 HEATR1 ECPAS TKT RFXANK EIF4A2 CDC20 TNPO3 BRF2 | 5.16e-07 | 1284 | 202 | 24 | 17353931 |
| Pubmed | ISG15 Connects Autophagy and IFN-γ-Dependent Control of Toxoplasma gondii Infection in Human Cells. | MYO1E VPS13C STAT1 STAT3 MYO5C EFTUD2 GCN1 DYNC1H1 DHX30 TKT ATP5F1A | 5.50e-07 | 268 | 202 | 11 | 33024031 |
| Pubmed | FOXK2 SIPA1L3 ZNF217 STAT1 GREB1L CYFIP1 BRCA1 INTS2 XRN1 KMT2A ALDH3A2 MTCH2 SUPT3H CLASP1 COX6A1 POLR2E POLR2H HEATR1 VIRMA CYFIP2 DHX30 CSNK1A1 RBM7 HLTF ATP5F1A IPMK | 6.69e-07 | 1497 | 202 | 26 | 31527615 | |
| Pubmed | 7.69e-07 | 4 | 202 | 3 | 37227155 | ||
| Pubmed | 7.69e-07 | 4 | 202 | 3 | 20513533 | ||
| Pubmed | HK2 ACACA ZNF217 POLA2 NCAPG2 SERPINB6 INTS2 XRN1 ZBTB40 KMT2A ATP13A3 ALDH3A2 GCN1 RAD54L ARID4A GNPTAB UBR4 XPO4 HEATR1 VIRMA DHX30 TKT RBM7 ATP5F1A | 9.23e-07 | 1327 | 202 | 24 | 32694731 | |
| Pubmed | RUFY1 binds Arl8b and mediates endosome-to-TGN CI-M6PR retrieval for cargo sorting to lysosomes. | ACACA PLEKHM1 EFTUD2 CYFIP1 KMT2A ALDH3A2 GCN1 DYNC1H1 IPO7 PPP2R1B PCCB ATP5F1A | 9.34e-07 | 344 | 202 | 12 | 36282215 |
| Pubmed | A revised nomenclature for transcribed human endogenous retroviral loci. | 1.34e-06 | 94 | 202 | 7 | 21542922 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | HK2 ACACA MYO1E ACO1 POLA2 STAT1 STAT3 EFTUD2 PARP6 CYFIP1 PSME4 AGL GCN1 DYNC1H1 RAD23A ANKFY1 IPO7 UBR4 POLR2E POLR2H BCCIP NR3C1 ECPAS PPP2R1B TNPO3 | 1.36e-06 | 1455 | 202 | 25 | 22863883 |
| Pubmed | 1.52e-06 | 61 | 202 | 6 | 27694478 | ||
| Pubmed | 1.91e-06 | 5 | 202 | 3 | 18642075 | ||
| Pubmed | 1.91e-06 | 5 | 202 | 3 | 7579387 | ||
| Pubmed | 1.91e-06 | 5 | 202 | 3 | 15159397 | ||
| Pubmed | Transcription factor Foxp3 and its protein partners form a complex regulatory network. | HK2 ATR NCAPG2 STAT3 GCN1 DYNC1H1 HEATR1 NR3C1 VIRMA DHX30 ELF1 ATM | 1.99e-06 | 370 | 202 | 12 | 22922362 |
| Pubmed | Identification of phagocytosis regulators using magnetic genome-wide CRISPR screens. | 2.05e-06 | 143 | 202 | 8 | 30397336 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | HK2 ACACA MYO1E LYSMD2 FNBP1L STAT3 EFTUD2 SERPINB6 CYFIP1 AGL GCN1 MTCH2 DYNC1H1 IPO7 DSG1 CLASP1 UBR4 POLR2E POLR2H DHX30 CSNK1A1 TKT HLTF ATP5F1A | 2.80e-06 | 1415 | 202 | 24 | 28515276 |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 3.09e-06 | 202 | 202 | 9 | 33005030 | |
| Pubmed | 3.17e-06 | 18 | 202 | 4 | 18664271 | ||
| Pubmed | NR2C1 FOXK2 ZNF217 CXXC1 STAT1 STAT3 MYO5C BRCA1 XRN1 ZBTB40 KMT2A DYNC1H1 SUPT3H DNAH10 ARID4A TNPO2 UBR4 COX6A1 E2F3 DHX30 RFXANK ELF1 PUM1 PCCB | 3.31e-06 | 1429 | 202 | 24 | 35140242 | |
| Pubmed | HK2 MYO1E L2HGDH NCAPG2 STAT3 EFTUD2 KMT2A ATP13A3 ALDH3A2 GCN1 DYNC1H1 IPO7 TNPO2 UBR4 POLR2E XPO4 HEATR1 ECPAS PPP2R1B HLTF ATM CDC20 TNPO3 ATP5F1A | 3.77e-06 | 1440 | 202 | 24 | 30833792 | |
| Pubmed | 3.81e-06 | 6 | 202 | 3 | 19805520 | ||
| Pubmed | The complexity of p53 modulation: emerging patterns from divergent signals. | 3.81e-06 | 6 | 202 | 3 | 9765199 | |
| Pubmed | ACACA STAT3 EFTUD2 CYFIP1 ALDH3A2 GCN1 DYNC1H1 ANKFY1 IPO7 UBR4 HEATR1 ECPAS DHX30 PUM1 TNPO3 | 5.55e-06 | 638 | 202 | 15 | 33239621 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | ACACA MYO1E ESRRA FNBP1L SEPTIN8 BRCA1 XRN1 GCN1 DSG1 CYFIP2 TKT CDC20 PUM1 ESPL1 PCCB NNT | 5.86e-06 | 724 | 202 | 16 | 36232890 |
| Pubmed | Physiological and pathophysiological characteristics of ataxin-3 isoforms. | ACACA EFTUD2 CYFIP1 GCN1 DYNC1H1 RAD23A IPO7 DSG1 TKT ATP5F1A | 6.44e-06 | 281 | 202 | 10 | 30455355 |
| Pubmed | A Stat3-interacting protein (StIP1) regulates cytokine signal transduction. | 6.64e-06 | 7 | 202 | 3 | 10954736 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | ACACA VPS13C CXXC1 AGL VPS13A MAP3K9 DYNC1H1 DNAH3 TNPO2 UBR4 DNAH2 ECPAS CEP295 ATM TNR SERPINA9 | 7.19e-06 | 736 | 202 | 16 | 29676528 |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | FOXK2 BTBD9 POLA2 EFTUD2 BRCA1 PAN2 ALDH3A2 GCN1 RAD23A SUPT3H ANKFY1 IPO7 DSG1 POLR2E PPP2R1B EIF4A2 HLTF UGGT2 TNPO3 | 7.26e-06 | 1005 | 202 | 19 | 19615732 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | FOXK2 ACACA MYO1E TMEM8B SIPA1L3 PLEKHM1 TYK2 TINAGL1 PSME4 PER2 GCN1 DYNC1H1 UBR4 COX6A1 TEP1 DHX30 LATS2 PUM1 ESPL1 TNPO3 | 7.82e-06 | 1105 | 202 | 20 | 35748872 |
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | STAT1 CYFIP1 XRN1 GCN1 IPO7 CLASP1 TNPO2 UBR4 HEATR1 ECPAS PPP2R1B CSNK1A1 TNPO3 | 7.90e-06 | 498 | 202 | 13 | 36634849 |
| Pubmed | GGA2 ACACA STAT1 CLASP1 UBR4 BCCIP HEATR1 EIF4A2 ESPL1 TNPO3 | 7.98e-06 | 288 | 202 | 10 | 23383273 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | NR2C1 ACACA STAT1 STAT3 EFTUD2 BTK KMT2A GCN1 DYNC1H1 UBR4 POLR2E POLR2H BCCIP HEATR1 DHX30 TKT EIF4A2 HLTF PUM1 PCCB TNPO3 ATP5F1A | 9.62e-06 | 1318 | 202 | 22 | 30463901 |
| Pubmed | ACACA NUP210L VPS13C FIG4 MTCH2 DYNC1H1 IPO7 POLR2E DNAH2 HEATR1 ECPAS CARD8 CSNK1A1 RBM7 HLTF PUM1 | 9.70e-06 | 754 | 202 | 16 | 35906200 | |
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | MYO1E STXBP4 POLA2 STAT3 INTS2 ATP13A3 GCN1 IPO7 TNPO2 XPO4 HEATR1 ECPAS INTS4 UGGT2 NNT TNPO3 | 9.70e-06 | 754 | 202 | 16 | 33060197 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | NR2C1 ACACA STXBP4 STAT1 STAT3 EFTUD2 XRN1 KMT2A ALDH3A2 GCN1 MTCH2 DSG1 HEATR1 NR3C1 DHX30 TKT DEPDC1B ATP5F1A | 9.87e-06 | 934 | 202 | 18 | 33916271 |
| Pubmed | Expanding the Interactome of TES by Exploiting TES Modules with Different Subcellular Localizations. | 1.05e-05 | 235 | 202 | 9 | 28378594 | |
| Pubmed | 1.06e-05 | 8 | 202 | 3 | 15456891 | ||
| Pubmed | ATM and PRDM9 regulate SPO11-bound recombination intermediates during meiosis. | 1.06e-05 | 8 | 202 | 3 | 32051414 | |
| Pubmed | HIV-1 Vpr-induced apoptosis is cell cycle dependent and requires Bax but not ANT. | 1.06e-05 | 8 | 202 | 3 | 17140287 | |
| Pubmed | CYLD Regulates Centriolar Satellites Proteostasis by Counteracting the E3 Ligase MIB1. | 1.21e-05 | 182 | 202 | 8 | 31067453 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | FOXK2 HK2 FNBP1L STAT1 STAT3 GK AGL A2ML1 ZBTB40 DYNC1H1 ARID4A UBR4 HEATR1 NR3C1 ECPAS CYFIP2 PUM1 | 1.22e-05 | 857 | 202 | 17 | 25609649 |
| Pubmed | 1.27e-05 | 25 | 202 | 4 | 34004147 | ||
| Pubmed | 1.28e-05 | 304 | 202 | 10 | 32235678 | ||
| Pubmed | 1.42e-05 | 186 | 202 | 8 | 14744259 | ||
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | NR2C1 FOXK2 POLA2 BRCA1 ZBTB40 KMT2A RAD23A IPO7 ARID4A BCCIP E2F3 RFXANK HLTF ELF1 | 1.45e-05 | 608 | 202 | 14 | 36089195 |
| Pubmed | 1.49e-05 | 26 | 202 | 4 | 23181366 | ||
| Pubmed | GGA2 VPS13C ADGRB3 SEPTIN8 PSME4 INTS2 PAN2 DAGLA XPO4 E2F3 ECPAS CAPRIN2 ESPL1 | 1.50e-05 | 529 | 202 | 13 | 14621295 | |
| Pubmed | 1.58e-05 | 9 | 202 | 3 | 23901102 | ||
| Pubmed | Vpr-induced DNA double-strand breaks: molecular mechanism and biological relevance. | 1.58e-05 | 9 | 202 | 3 | 19275579 | |
| Pubmed | 1.58e-05 | 9 | 202 | 3 | 12817007 | ||
| Pubmed | 1.58e-05 | 9 | 202 | 3 | 16493033 | ||
| Pubmed | 1.58e-05 | 9 | 202 | 3 | 9484840 | ||
| Pubmed | 1.58e-05 | 9 | 202 | 3 | 20065083 | ||
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | ACACA ACO1 FNBP1L STAT1 EFTUD2 IVL CYFIP1 AGL A2ML1 GCN1 MTCH2 RAD23A DSG1 CLASP1 UBR4 BCCIP NR3C1 ECPAS PPP2R1B EIF4A2 NNT ATP5F1A | 1.69e-05 | 1367 | 202 | 22 | 32687490 |
| Pubmed | MYO1E CYP24A1 FNBP1L KMT2A ALDH3A2 GCN1 DYNC1H1 UBR4 POLR2H PRXL2A HEATR1 ECPAS CSNK1A1 TKT ATP5F1A | 1.98e-05 | 711 | 202 | 15 | 33022573 | |
| Pubmed | 2.03e-05 | 28 | 202 | 4 | 20012529 | ||
| Pubmed | Evidence that the transcriptional repressor ICER is regulated via the N-end rule for ubiquitination. | 2.03e-05 | 28 | 202 | 4 | 35227662 | |
| Pubmed | BRCA2 mediates centrosome cohesion via an interaction with cytoplasmic dynein. | 2.06e-05 | 57 | 202 | 5 | 27433848 | |
| Pubmed | FOXK2 STXBP4 STAT1 SEPTIN8 PSME4 INTS2 ZBTB40 PAN2 MAP3K9 RALGPS2 HEATR1 WDFY4 EIF4A2 PRKCD CEP295 PUM1 ESPL1 ATP5F1A IPMK | 2.07e-05 | 1084 | 202 | 19 | 11544199 | |
| Pubmed | NR2C1 MYO1E ACO1 SIPA1L3 ADGRB3 STAT1 STAT3 DYNC1H1 VLDLR TNPO2 GNPTAB UBR4 E2F3 DHX30 GUCY1B1 EIF4A2 CEP70 RORB ATM PCCB ATP5F1A | 2.12e-05 | 1285 | 202 | 21 | 35914814 | |
| Pubmed | 2.15e-05 | 323 | 202 | 10 | 24797263 | ||
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | ACACA ACO1 EFTUD2 KMT2A GCN1 MTCH2 DYNC1H1 UBR4 ECPAS CYFIP2 EPG5 CSNK1A1 TKT PCCB NNT ATP5F1A | 2.22e-05 | 807 | 202 | 16 | 30575818 |
| Pubmed | 2.25e-05 | 10 | 202 | 3 | 17478428 | ||
| Pubmed | JAK-STAT signaling maintains homeostasis in T cells and macrophages. | 2.25e-05 | 10 | 202 | 3 | 38658806 | |
| Pubmed | 2.25e-05 | 10 | 202 | 3 | 24069548 | ||
| Pubmed | 2.25e-05 | 10 | 202 | 3 | 37592023 | ||
| Pubmed | 2.25e-05 | 10 | 202 | 3 | 18514189 | ||
| Pubmed | A single phosphotyrosine residue of Stat91 required for gene activation by interferon-gamma. | 2.25e-05 | 10 | 202 | 3 | 7690989 | |
| Pubmed | NR2C1 FOXK2 ZNF217 NCAPG2 STAT1 BRCA1 ZBTB40 KMT2A DYNC1H1 RAD23A IPO7 CLASP1 TNPO2 ECPAS CSNK1A1 TKT HLTF ELF1 TNPO3 | 2.63e-05 | 1103 | 202 | 19 | 34189442 | |
| Pubmed | Histone methyltransferase DOT1L coordinates AR and MYC stability in prostate cancer. | 2.63e-05 | 264 | 202 | 9 | 32814769 | |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | STAT1 STAT3 EFTUD2 CYFIP1 INTS2 ALDH3A2 MTCH2 IPO7 DSG1 CLASP1 COX6A1 HEATR1 VIRMA TMEM38B PEX26 CYFIP2 RBM7 CDC20 NNT TNPO3 | 2.64e-05 | 1203 | 202 | 20 | 29180619 |
| Pubmed | 2.87e-05 | 61 | 202 | 5 | 19875381 | ||
| Pubmed | Alternative Functions of Cell Cycle-Related and DNA Repair Proteins in Post-mitotic Neurons. | 2.87e-05 | 61 | 202 | 5 | 34746147 | |
| Pubmed | FOXK2 ATR POLA2 STAT1 STAT3 KMT2A RAD23A IPO7 UBR4 POLR2E POLR2H BCCIP ECPAS VIRMA CSNK1A1 TKT HLTF ATM | 2.93e-05 | 1014 | 202 | 18 | 32416067 | |
| Pubmed | Protein kinase Cdelta regulates apoptosis via activation of STAT1. | 3.08e-05 | 11 | 202 | 3 | 15322115 | |
| Pubmed | Asthma and genes encoding components of the vitamin D pathway. | 3.08e-05 | 11 | 202 | 3 | 19852851 | |
| Pubmed | ACACA XRN1 KMT2A GCN1 DYNC1H1 IPO7 UBR4 HEATR1 ECPAS VIRMA DHX30 ATM PUM1 NNT | 3.16e-05 | 653 | 202 | 14 | 22586326 | |
| Pubmed | Single-stranded DNA orchestrates an ATM-to-ATR switch at DNA breaks. | 3.36e-05 | 2 | 202 | 2 | 19285939 | |
| Pubmed | 3.36e-05 | 2 | 202 | 2 | 28851706 | ||
| Pubmed | 3.36e-05 | 2 | 202 | 2 | 32357246 | ||
| Pubmed | Mechanisms of increased risk of tumorigenesis in Atm and Brca1 double heterozygosity. | 3.36e-05 | 2 | 202 | 2 | 21849032 | |
| Interaction | GPR45 interactions | ATR CYP24A1 L2HGDH NCAPG2 STAT1 STAT3 INTS2 ATP13A3 GCN1 MMS22L TNPO2 XPO4 HEATR1 ECPAS PPP2R1B HLTF ATM TNPO3 | 7.70e-10 | 300 | 194 | 18 | int:GPR45 |
| Interaction | OPALIN interactions | ATR NCAPG2 INTS2 ATP13A3 GCN1 MTCH2 TNPO2 XPO4 HEATR1 ECPAS PRKCD ATM TNPO3 | 1.25e-07 | 209 | 194 | 13 | int:OPALIN |
| Interaction | BRCA2 interactions | ATR GREB1L TYK2 BRCA1 FIG4 KMT2A DYNC1H1 RAD23A SUPT3H MMS22L BCCIP TEP1 HELQ VIRMA CARD8 RFXANK ATM | 2.00e-07 | 384 | 194 | 17 | int:BRCA2 |
| Interaction | P2RY8 interactions | CYP24A1 NCAPG2 INTS2 ATP13A3 GCN1 XPO4 HEATR1 ECPAS CYFIP2 ATM TNPO3 | 1.34e-06 | 179 | 194 | 11 | int:P2RY8 |
| Interaction | INTS3 interactions | ATR EFTUD2 INTS2 ALDH3A2 POLR2E POLR2H NR3C1 VIRMA PPP2R1B INTS4 | 1.75e-06 | 148 | 194 | 10 | int:INTS3 |
| Interaction | C19orf38 interactions | 1.78e-06 | 86 | 194 | 8 | int:C19orf38 | |
| Interaction | YWHAH interactions | MYO1E STXBP4 SIPA1L3 POLA2 EFTUD2 IFIH1 PTPN3 CYFIP1 XRN1 MAP3K9 KMT2A MAP3K15 MACIR ARAP2 CLASP1 RALGPS2 NR3C1 VIRMA DNAH7 CYFIP2 LATS2 CSNK1A1 RBM7 EXO1 CRYBG3 CDC20 PUM1 DEPDC1B | 2.51e-06 | 1102 | 194 | 28 | int:YWHAH |
| Interaction | VIPR2 interactions | NCAPG2 INTS2 ATP13A3 MMS22L TNPO2 XPO4 HEATR1 VIRMA CYFIP2 TNPO3 ATP5F1A | 2.95e-06 | 194 | 194 | 11 | int:VIPR2 |
| Interaction | SCN2B interactions | 3.79e-06 | 95 | 194 | 8 | int:SCN2B | |
| Interaction | MLNR interactions | 4.06e-06 | 68 | 194 | 7 | int:MLNR | |
| Interaction | PTPRA interactions | 4.40e-06 | 164 | 194 | 10 | int:PTPRA | |
| Interaction | PPP2CA interactions | ACACA ZNF217 EFTUD2 BRCA1 INTS2 XRN1 POLR2E NR3C1 PPP2R1B CSNK1A1 KLHDC8A INTS4 PRKCD ATM CDC20 ESPL1 TNPO3 | 4.77e-06 | 484 | 194 | 17 | int:PPP2CA |
| Interaction | VSIG1 interactions | 5.97e-06 | 72 | 194 | 7 | int:VSIG1 | |
| Interaction | PIH1D1 interactions | ACACA LYSMD2 STAT3 EFTUD2 TYK2 SERPINB6 CYFIP1 AGL KMT2A GCN1 MTCH2 DYNC1H1 IPO7 UBR4 POLR2E POLR2H DHX30 PPP1R3A LATS2 TKT ATP5F1A | 8.20e-06 | 731 | 194 | 21 | int:PIH1D1 |
| Interaction | HDAC1 interactions | NR2C1 FOXK2 ACACA ATR ZNF217 STAT1 STAT3 EFTUD2 BRCA1 XRN1 KMT2A GCN1 ANKFY1 ARID4A TNPO2 UBR4 E2F3 NR3C1 ECPAS VIRMA PPP2R1B LATS2 ATM CRYBG3 CDC20 PCCB TNPO3 | 8.31e-06 | 1108 | 194 | 27 | int:HDAC1 |
| Interaction | YWHAZ interactions | SIPA1L3 EFTUD2 PTPN3 CYFIP1 BRCA1 PER2 MAP3K9 KMT2A MAP3K15 ALDH3A2 MTCH2 MACIR DYNC1H1 ARAP2 IPO7 CLASP1 RALGPS2 VIRMA CYFIP2 LATS2 CSNK1A1 CD28 TKT RBM7 EXO1 PRKCD ATM PUM1 DEPDC1B ATP5F1A | 9.61e-06 | 1319 | 194 | 30 | int:YWHAZ |
| Interaction | INTS6 interactions | 1.13e-05 | 110 | 194 | 8 | int:INTS6 | |
| Interaction | BSG interactions | ATR CYP24A1 NCAPG2 GK GCN1 IPO7 CLASP1 TNPO2 XPO4 TMPRSS4 HEATR1 NR3C1 ECPAS VIRMA PPP2R1B RFXANK ATM NNT TNPO3 | 1.18e-05 | 631 | 194 | 19 | int:BSG |
| Interaction | VSIG2 interactions | 1.28e-05 | 32 | 194 | 5 | int:VSIG2 | |
| Interaction | PDGFRB interactions | FOXK2 ATR MYO1E STAT1 STAT3 TYK2 SEPTIN8 ALDH3A2 UBR4 VIRMA INTS4 | 1.37e-05 | 228 | 194 | 11 | int:PDGFRB |
| Interaction | C3orf18 interactions | 1.57e-05 | 115 | 194 | 8 | int:C3orf18 | |
| Interaction | HSPB1 interactions | RBM48 NFU1 STAT3 EFTUD2 TYK2 PTPN3 BRCA1 GCN1 MTCH2 DYNC1H1 RAD23A IPO7 ECPAS VIRMA TKT EIF4A2 PRKCD PUM1 NNT ATP5F1A | 1.74e-05 | 708 | 194 | 20 | int:HSPB1 |
| Interaction | TNFSF13B interactions | 2.01e-05 | 119 | 194 | 8 | int:TNFSF13B | |
| Interaction | PACC1 interactions | 2.01e-05 | 119 | 194 | 8 | int:PACC1 | |
| Interaction | GPR17 interactions | ATR INTS2 ATP13A3 MMS22L TNPO2 PRXL2A XPO4 HEATR1 ECPAS MFSD8 ATM TNPO3 | 2.02e-05 | 283 | 194 | 12 | int:GPR17 |
| Interaction | COMTD1 interactions | 2.50e-05 | 200 | 194 | 10 | int:COMTD1 | |
| Interaction | FAM234A interactions | 3.04e-05 | 126 | 194 | 8 | int:FAM234A | |
| Interaction | CD70 interactions | 3.40e-05 | 166 | 194 | 9 | int:CD70 | |
| Interaction | KIR2DL4 interactions | 3.47e-05 | 94 | 194 | 7 | int:KIR2DL4 | |
| Interaction | FZD10 interactions | 4.14e-05 | 66 | 194 | 6 | int:FZD10 | |
| Interaction | GYPA interactions | 4.91e-05 | 174 | 194 | 9 | int:GYPA | |
| Interaction | PARP4 interactions | 5.00e-05 | 42 | 194 | 5 | int:PARP4 | |
| Interaction | INTS1 interactions | 5.14e-05 | 175 | 194 | 9 | int:INTS1 | |
| Interaction | B3GNT8 interactions | 5.32e-05 | 22 | 194 | 4 | int:B3GNT8 | |
| Interaction | TTI1 interactions | 5.51e-05 | 101 | 194 | 7 | int:TTI1 | |
| Interaction | RUFY1 interactions | ACACA EFTUD2 CYFIP1 PSME4 BRCA1 KMT2A ALDH3A2 GCN1 DYNC1H1 ANKFY1 IPO7 VIRMA PPP2R1B PCCB ATP5F1A | 6.10e-05 | 476 | 194 | 15 | int:RUFY1 |
| Interaction | CD274 interactions | ACACA ATR INTS2 GCN1 ANKFY1 IPO7 DSG1 TNPO2 XPO4 HEATR1 TKT ATM TNPO3 | 6.27e-05 | 369 | 194 | 13 | int:CD274 |
| Interaction | NYAP2 interactions | 6.39e-05 | 23 | 194 | 4 | int:NYAP2 | |
| Interaction | SNCA interactions | VPS13C STAT1 EFTUD2 CYFIP1 XRN1 GCN1 DYNC1H1 IPO7 CLASP1 UBR4 POLR2H HEATR1 ECPAS VIRMA PPP2R1B CSNK1A1 PRKCD CEP295 TNPO3 | 6.59e-05 | 716 | 194 | 19 | int:SNCA |
| Interaction | NFIX interactions | 7.30e-05 | 227 | 194 | 10 | int:NFIX | |
| Interaction | P2RY10 interactions | 7.50e-05 | 106 | 194 | 7 | int:P2RY10 | |
| Interaction | RPS6KA5 interactions | 7.86e-05 | 144 | 194 | 8 | int:RPS6KA5 | |
| Interaction | NPTN interactions | ATR FIG4 GCN1 MMS22L TNPO2 COX6A1 XPO4 HEATR1 ECPAS ATM TNPO3 | 8.38e-05 | 278 | 194 | 11 | int:NPTN |
| Interaction | ARPC5 interactions | 9.48e-05 | 110 | 194 | 7 | int:ARPC5 | |
| Interaction | CYB5B interactions | ATR MTCH2 TNPO2 XPO4 NR3C1 ECPAS VIRMA TMEM38B ATM PUM1 TNPO3 | 1.04e-04 | 285 | 194 | 11 | int:CYB5B |
| Interaction | KDM1A interactions | NR2C1 ACACA ZNF217 GDF9 STAT3 EFTUD2 GREB1L BRCA1 INTS2 XRN1 GCN1 ANKFY1 TNPO2 UBR4 TDO2 NR3C1 ECPAS VIRMA CSNK1A1 CEP70 CRYBG3 PCCB | 1.12e-04 | 941 | 194 | 22 | int:KDM1A |
| Interaction | AKAP1 interactions | HK2 VPS13C GK VPS13A ALDH3A2 MTCH2 DYNC1H1 PGS1 UBR4 PRXL2A DHX30 PRKCD PUM1 DEPDC1B TNPO3 | 1.13e-04 | 503 | 194 | 15 | int:AKAP1 |
| Interaction | CD80 interactions | 1.14e-04 | 79 | 194 | 6 | int:CD80 | |
| Interaction | CD40 interactions | 1.20e-04 | 153 | 194 | 8 | int:CD40 | |
| Interaction | SFN interactions | STXBP4 SIPA1L3 STAT3 IVL PTPN3 KMT2A ARAP2 CLASP1 RALGPS2 NR3C1 VIRMA CARD8 CYFIP2 TKT RBM7 EXO1 CRYBG3 PUM1 | 1.32e-04 | 692 | 194 | 18 | int:SFN |
| Interaction | COPS5 interactions | BTBD9 STAT1 STAT3 EFTUD2 TYK2 TINAGL1 CYFIP1 PSME4 AGL ALDH3A2 DYNC1H1 DSG1 TNPO2 UBR4 POLR2E DNAH2 VIRMA CYFIP2 DHX30 CSNK1A1 ATM CDC20 PUM1 ATP5F1A | 1.58e-04 | 1102 | 194 | 24 | int:COPS5 |
| Interaction | YWHAG interactions | STXBP4 SIPA1L3 STAT3 EFTUD2 PTPN3 CYFIP1 MAP3K9 KMT2A MACIR DYNC1H1 ARAP2 CLASP1 RALGPS2 VIRMA DNAH7 CYFIP2 LATS2 CSNK1A1 RBM7 EXO1 PRKCD CDC20 PUM1 DEPDC1B TNPO3 ATP5F1A | 1.68e-04 | 1248 | 194 | 26 | int:YWHAG |
| Interaction | LRRC31 interactions | 1.72e-04 | 205 | 194 | 9 | int:LRRC31 | |
| Interaction | HCST interactions | 1.72e-04 | 205 | 194 | 9 | int:HCST | |
| Interaction | RHEB interactions | 1.94e-04 | 164 | 194 | 8 | int:RHEB | |
| Interaction | TNPO1 interactions | MYO1E BRCA1 PTPRM MACIR IPO7 TNPO2 UBR4 TMPRSS4 VIRMA CSNK1A1 TNPO3 | 1.94e-04 | 306 | 194 | 11 | int:TNPO1 |
| Interaction | TPST2 interactions | 2.00e-04 | 124 | 194 | 7 | int:TPST2 | |
| Interaction | RAN interactions | EFTUD2 TYK2 BRCA1 AGL PAN2 KMT2A VLDLR IPO7 TNPO2 XPO4 NR3C1 ECPAS WDFY4 VIRMA | 2.15e-04 | 475 | 194 | 14 | int:RAN |
| Interaction | SPN interactions | 2.19e-04 | 57 | 194 | 5 | int:SPN | |
| Interaction | TANC2 interactions | 2.21e-04 | 89 | 194 | 6 | int:TANC2 | |
| Interaction | SP1 interactions | MYO1E ESRRA STAT3 BRCA1 KMT2A DYNC1H1 ARID4A E2F3 NR3C1 HLTF PRKCD ELF1 | 2.28e-04 | 365 | 194 | 12 | int:SP1 |
| Interaction | KIAA0513 interactions | 2.34e-04 | 13 | 194 | 3 | int:KIAA0513 | |
| Interaction | AR interactions | NR2C1 VPS13C ZNF217 STAT3 MYO5C EFTUD2 GRHL1 CYFIP1 BRCA1 BTK KMT2A GCN1 DYNC1H1 POLR2H NR3C1 ECPAS VIRMA LATS2 CSNK1A1 TKT INTS4 ATP5F1A | 2.35e-04 | 992 | 194 | 22 | int:AR |
| Interaction | PTEN interactions | TDRD15 ACACA CXXC1 NFU1 EFTUD2 IFIH1 SERPINB6 KMT2A RAD54L IPO7 DSG1 POLR2H NR3C1 CSNK1A1 TKT CAPRIN2 ATM PCCB NNT TNPO3 ATP5F1A | 2.54e-04 | 929 | 194 | 21 | int:PTEN |
| Interaction | VTRNA1-2 interactions | 2.75e-04 | 3 | 194 | 2 | int:VTRNA1-2 | |
| Interaction | PLEC interactions | ATR EFTUD2 BRCA1 PER2 PAN2 DNAH3 WDFY4 VIRMA CYFIP2 LRRC31 TKT EXO1 DEPDC1B | 2.84e-04 | 430 | 194 | 13 | int:PLEC |
| Interaction | KCNA3 interactions | STAT1 STAT3 MYO5C CYFIP1 KCNA1 KCNA4 VPS13A XRN1 KMT2A ALDH3A2 GCN1 DYNC1H1 IPO7 ECPAS HELQ CAPRIN2 CRYBG3 DEPDC1B ATP5F1A TDRD12 | 2.93e-04 | 871 | 194 | 20 | int:KCNA3 |
| Interaction | KATNB1 interactions | 3.02e-04 | 61 | 194 | 5 | int:KATNB1 | |
| Interaction | WEE1 interactions | 3.08e-04 | 133 | 194 | 7 | int:WEE1 | |
| Interaction | IFNAR2 interactions | 3.08e-04 | 34 | 194 | 4 | int:IFNAR2 | |
| Interaction | MGARP interactions | 3.11e-04 | 222 | 194 | 9 | int:MGARP | |
| Interaction | MED12 interactions | 3.13e-04 | 176 | 194 | 8 | int:MED12 | |
| Interaction | RP2 interactions | 3.15e-04 | 95 | 194 | 6 | int:RP2 | |
| Interaction | IPO13 interactions | 3.15e-04 | 95 | 194 | 6 | int:IPO13 | |
| Interaction | YWHAB interactions | SIPA1L3 NFU1 EFTUD2 PTPN3 CYFIP1 MAP3K9 KMT2A MACIR DYNC1H1 ARAP2 CLASP1 GNPTAB RALGPS2 BCCIP VIRMA CYFIP2 TKT RBM7 EXO1 PRKCD PUM1 ATP5F1A | 3.18e-04 | 1014 | 194 | 22 | int:YWHAB |
| Interaction | RCOR1 interactions | NR2C1 FOXK2 ACACA ZNF217 XRN1 GCN1 ANKFY1 ARID4A TNPO2 UBR4 NR3C1 ECPAS VIRMA PCCB | 3.21e-04 | 494 | 194 | 14 | int:RCOR1 |
| Interaction | NFYC interactions | 3.25e-04 | 177 | 194 | 8 | int:NFYC | |
| Interaction | FAM174A interactions | 3.32e-04 | 224 | 194 | 9 | int:FAM174A | |
| Interaction | DCAF1 interactions | 3.32e-04 | 224 | 194 | 9 | int:DCAF1 | |
| Interaction | KANSL1 interactions | 3.33e-04 | 96 | 194 | 6 | int:KANSL1 | |
| Interaction | SINHCAF interactions | 3.37e-04 | 135 | 194 | 7 | int:SINHCAF | |
| Interaction | C9orf78 interactions | L2HGDH POLA2 STAT3 EFTUD2 CYFIP1 ALDH3A2 DYNC1H1 IPO7 TNPO2 ECPAS HLTF INTS4 PUM1 NNT TNPO3 ATP5F1A | 3.44e-04 | 620 | 194 | 16 | int:C9orf78 |
| Interaction | CDK9 interactions | ACACA ATR MYO1E SIPA1L3 STAT1 STAT3 EFTUD2 BRCA1 INTS2 AGL KMT2A CSNK1A1 HLTF ATM CDC20 ESPL1 ATP5F1A | 3.52e-04 | 685 | 194 | 17 | int:CDK9 |
| Interaction | LYSMD2 interactions | 3.67e-04 | 15 | 194 | 3 | int:LYSMD2 | |
| Interaction | P2RY6 interactions | ATP13A3 ALDH3A2 GCN1 IPO7 UBR4 POLR2E XPO4 HEATR1 ECPAS PPP2R1B TNPO3 ATP5F1A | 3.70e-04 | 385 | 194 | 12 | int:P2RY6 |
| Interaction | GNB2 interactions | ACACA VPS13C L2HGDH GDF9 STAT1 STAT3 TINAGL1 PAN2 NR3C1 ECPAS DHX30 CSNK1A1 PCCB ATP5F1A | 3.77e-04 | 502 | 194 | 14 | int:GNB2 |
| Interaction | AP5B1 interactions | 3.85e-04 | 36 | 194 | 4 | int:AP5B1 | |
| Interaction | LRRC25 interactions | 4.37e-04 | 185 | 194 | 8 | int:LRRC25 | |
| GeneFamily | Dyneins, axonemal | 5.15e-06 | 17 | 127 | 4 | 536 | |
| GeneFamily | Armadillo repeat containing|Importins | 2.56e-04 | 18 | 127 | 3 | 596 | |
| GeneFamily | Nuclear hormone receptors | 3.85e-04 | 49 | 127 | 4 | 71 | |
| GeneFamily | Myosins, class I | 1.33e-03 | 8 | 127 | 2 | 1097 | |
| GeneFamily | Serpin peptidase inhibitors | 2.21e-03 | 37 | 127 | 3 | 739 | |
| GeneFamily | X-linked mental retardation|RNA helicases | 2.58e-03 | 11 | 127 | 2 | 1168 | |
| GeneFamily | Zinc fingers CXXC-type | 3.09e-03 | 12 | 127 | 2 | 136 | |
| Coexpression | GSE45365_WT_VS_IFNAR_KO_CD8A_DC_MCMV_INFECTION_UP | PLEKHM1 STAT1 TYK2 KMT2A CLASP1 MYO1F ZNF75D PRKCD CRYBG3 TNPO3 | 2.38e-06 | 199 | 193 | 10 | M9964 |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | ZNF217 FNBP1L PTPN3 PER2 VPS13A ATP13A3 VLDLR CLASP1 E2F3 PRKCD ELF1 PUM1 | 2.53e-06 | 300 | 193 | 12 | M8702 |
| Coexpression | GSE360_L_MAJOR_VS_B_MALAYI_HIGH_DOSE_DC_DN | 1.64e-05 | 197 | 193 | 9 | M5210 | |
| Coexpression | GSE28726_NAIVE_VS_ACTIVATED_CD4_TCELL_DN | 1.78e-05 | 199 | 193 | 9 | M8314 | |
| Coexpression | GSE40273_XBP1_KO_VS_WT_TREG_DN | 1.78e-05 | 199 | 193 | 9 | M9124 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | FOXK2 ATR FNBP1L PSME4 BRCA1 PTPRM VPS13A ATP13A3 ARAP2 VLDLR IPO7 CLASP1 ARID4A E2F3 NR3C1 CSNK1A1 HLTF CRYBG3 PUM1 | 2.02e-05 | 856 | 193 | 19 | M4500 |
| Coexpression | DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP | L2HGDH POLA2 NCAPG2 BRCA1 RAD54L MMS22L TMEM38B TMED8 EXO1 ESPL1 DEPDC1B | 2.98e-05 | 323 | 193 | 11 | M2156 |
| Coexpression | HOSHIDA_LIVER_CANCER_SUBCLASS_S3 | MYO1E ACO1 ACOX2 TINAGL1 AGL ALDH3A2 TDO2 CYFIP2 PPP2R1B PCCB | 3.00e-05 | 266 | 193 | 10 | M1286 |
| Coexpression | STEIN_ESRRA_TARGETS | ESRRA CYP24A1 NFU1 SEPTIN8 GK ALDH3A2 ARID4A PEX26 RFXANK CAPRIN2 CEP70 AP5M1 RBM7 NNT | 4.09e-05 | 529 | 193 | 14 | M843 |
| Coexpression | GSE25146_UNSTIM_VS_HELIOBACTER_PYLORI_LPS_STIM_AGS_CELL_UP | 5.93e-05 | 180 | 193 | 8 | M8127 | |
| Coexpression | GAVIN_FOXP3_TARGETS_CLUSTER_P6 | 6.61e-05 | 93 | 193 | 6 | M1735 | |
| Coexpression | GAVIN_FOXP3_TARGETS_CLUSTER_P6 | 7.44e-05 | 95 | 193 | 6 | MM1217 | |
| Coexpression | KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP | GGA2 HK2 ATR POLA2 NCAPG2 BRCA1 PER2 RAD54L RAD23A IPO7 RALGPS2 BCCIP XPO4 TMEM38B PPP2R1B TKT AP5M1 HLTF EXO1 CDC20 ESPL1 DEPDC1B BRF2 | 8.24e-05 | 1290 | 193 | 23 | M80 |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP | ACACA NFU1 GK CYFIP1 BTK KMT2A ATP13A3 DYNC1H1 ARAP2 SUPT3H ANKFY1 IPO7 NR3C1 ECPAS TMEM38B CARD8 CYFIP2 CSNK1A1 PRKCD ELF1 ATM PUM1 | 9.51e-05 | 1215 | 193 | 22 | M41122 |
| Coexpression | GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_72H_ACT_CD4_TCELL_DN | 1.04e-04 | 195 | 193 | 8 | M4233 | |
| Coexpression | GSE40666_STAT1_KO_VS_STAT4_KO_CD8_TCELL_WITH_IFNA_STIM_90MIN_UP | 1.04e-04 | 195 | 193 | 8 | M9218 | |
| Coexpression | FISCHER_DREAM_TARGETS | ACACA POLA2 NCAPG2 STAT1 IFIH1 BRCA1 MACIR RAD54L RAD23A MMS22L TNPO2 HEATR1 HLTF EXO1 CEP295 CDC20 ESPL1 DEPDC1B TNPO3 | 1.06e-04 | 969 | 193 | 19 | M149 |
| Coexpression | GSE8835_CD4_VS_CD8_TCELL_DN | ODAD1 CYP24A1 ADGRB3 LYSMD2 SERPINB11 TMEM38B FAM135B ZDHHC19 | 1.15e-04 | 198 | 193 | 8 | M6255 |
| Coexpression | RODWELL_AGING_KIDNEY_NO_BLOOD_DN | 1.17e-04 | 148 | 193 | 7 | M11837 | |
| Coexpression | GSE1460_CD4_THYMOCYTE_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_UP | 1.19e-04 | 199 | 193 | 8 | M3474 | |
| Coexpression | GSE21927_SPLEEN_C57BL6_VS_EL4_TUMOR_BALBC_MONOCYTES_UP | 1.19e-04 | 199 | 193 | 8 | M7596 | |
| Coexpression | GSE3982_MAC_VS_TH2_UP | 1.19e-04 | 199 | 193 | 8 | M5513 | |
| Coexpression | GSE22886_UNSTIM_VS_IL2_STIM_NKCELL_DN | 1.24e-04 | 200 | 193 | 8 | M4531 | |
| Coexpression | GSE33424_CD161_HIGH_VS_NEG_CD8_TCELL_UP | 1.24e-04 | 200 | 193 | 8 | M8541 | |
| Coexpression | GSE27859_DC_VS_CD11C_INT_F480_INT_DC_UP | 1.24e-04 | 200 | 193 | 8 | M8596 | |
| Coexpression | GSE32986_UNSTIM_VS_CURDLAN_HIGHDOSE_STIM_DC_UP | 1.24e-04 | 200 | 193 | 8 | M8614 | |
| Coexpression | GSE26343_UNSTIM_VS_LPS_STIM_MACROPHAGE_DN | 1.24e-04 | 200 | 193 | 8 | M8648 | |
| Coexpression | GSE360_CTRL_VS_T_GONDII_MAC_UP | 1.24e-04 | 200 | 193 | 8 | M5162 | |
| Coexpression | HALLMARK_G2M_CHECKPOINT | 1.24e-04 | 200 | 193 | 8 | M5901 | |
| Coexpression | GSE5542_IFNG_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_6H_UP | 1.24e-04 | 200 | 193 | 8 | M6531 | |
| Coexpression | GSE36527_CD69_NEG_VS_POS_TREG_CD62L_LOS_KLRG1_NEG_UP | 1.24e-04 | 200 | 193 | 8 | M9030 | |
| Coexpression | GSE3982_NKCELL_VS_TH2_DN | 1.24e-04 | 200 | 193 | 8 | M5598 | |
| Coexpression | GSE40274_GATA1_VS_FOXP3_AND_GATA1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP | 1.24e-04 | 200 | 193 | 8 | M9164 | |
| Coexpression | STEIN_ESRRA_TARGETS_UP | ESRRA CYP24A1 NFU1 GK ALDH3A2 PEX26 CAPRIN2 CEP70 AP5M1 RBM7 NNT | 1.43e-04 | 385 | 193 | 11 | M18491 |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_7DY_NEGATIVE | STAT3 PSME4 CLASP1 HEATR1 ECPAS HELQ VIRMA DHX30 EPG5 CSNK1A1 EIF4A2 ELF1 | 2.20e-04 | 474 | 193 | 12 | M40991 |
| CoexpressionAtlas | dev gonad_e11.5_M_PrimGermCell_Oct_top-relative-expression-ranked_1000 | ATR ZNF217 NCAPG2 EFTUD2 PTPN3 BRCA1 MAP3K15 RAD54L MMS22L XPO4 HEATR1 EIF4A2 CAPRIN2 CEP70 HLTF EXO1 ATM ESPL1 HBE1 IPMK TDRD12 | 7.36e-06 | 781 | 190 | 21 | gudmap_dev gonad_e11.5_M_PrimGermCell_Oct_1000 |
| CoexpressionAtlas | dev gonad_e12.5_M_GermCellTestis_Oct_top-relative-expression-ranked_1000 | ATR ZNF217 NCAPG2 PLEKHM1 EFTUD2 PTPN3 BRCA1 MAP3K15 RAD54L MMS22L XPO4 HEATR1 EIF4A2 CAPRIN2 CEP70 HLTF EXO1 ATM ESPL1 IPMK TDRD12 | 9.64e-06 | 795 | 190 | 21 | gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_1000 |
| CoexpressionAtlas | dev gonad_e11.5_F_PrimGermCell_Oct_top-relative-expression-ranked_1000 | ATR ZNF217 NCAPG2 MYO5C PTPN3 BRCA1 MAP3K15 RAD54L MMS22L XPO4 HEATR1 EIF4A2 CAPRIN2 CEP70 HLTF EXO1 ATM ESPL1 HBE1 IPMK TDRD12 | 1.04e-05 | 799 | 190 | 21 | gudmap_dev gonad_e11.5_F_PrimGermCell_Oct_1000 |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_top-relative-expression-ranked_1000 | ATR ZNF217 NCAPG2 EFTUD2 PTPN3 BRCA1 VPS13A MAP3K15 RAD54L MMS22L XPO4 HEATR1 EIF4A2 CAPRIN2 CEP70 HLTF EXO1 ATM ESPL1 IPMK TDRD12 | 1.59e-05 | 822 | 190 | 21 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_1000 |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_top-relative-expression-ranked_500 | ATR ZNF217 NCAPG2 PTPN3 BRCA1 MAP3K15 RAD54L MMS22L HEATR1 CAPRIN2 EXO1 ATM ESPL1 TDRD12 | 1.86e-05 | 406 | 190 | 14 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_500 |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_500 | ATR NCAPG2 BRCA1 VPS13A MAP3K15 RAD54L SUPT3H MMS22L CYP2R1 CAPRIN2 ATM ESPL1 TDRD12 | 4.61e-05 | 385 | 190 | 13 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_500 |
| CoexpressionAtlas | dev gonad_e11.5_F_PrimGermCell_Oct_k-means-cluster#3_top-relative-expression-ranked_1000 | ZNF217 PTPN3 BRCA1 RAD54L MMS22L XPO4 HEATR1 EIF4A2 CEP70 HLTF EXO1 ESPL1 IPMK TDRD12 | 7.72e-05 | 463 | 190 | 14 | gudmap_dev gonad_e11.5_F_PrimGermCell_Oct_k3_1000 |
| CoexpressionAtlas | B cells, preB.FrC.BM, CD19+ IgM- CD45R+ CD43+ HSA+, Bone marrow, avg-3 | KANSL1L NCAPG2 BRCA1 BTK RAD54L MMS22L RALGPS2 E2F3 WDFY4 EXO1 CDC20 ESPL1 DEPDC1B | 8.50e-05 | 409 | 190 | 13 | GSM399452_500 |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000 | ACACA ATR ZNF217 NCAPG2 BRCA1 VPS13A MAP3K15 RAD54L SUPT3H MMS22L HEATR1 CYP2R1 CAPRIN2 EXO1 CEP295 ATM ESPL1 IPMK TDRD12 | 1.49e-04 | 820 | 190 | 19 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000 |
| CoexpressionAtlas | B cells, B.GC.Sp, CD19+ IgM+ IgD- GL7+ PNA+, Spleen, avg-3 | GGA2 MYO1E NCAPG2 SLC41A2 BRCA1 BTK RAD54L MMS22L RALGPS2 HELQ EXO1 CDC20 | 1.69e-04 | 380 | 190 | 12 | GSM538207_500 |
| CoexpressionAtlas | dev gonad_e12.5_M_GermCellTestis_Oct_top-relative-expression-ranked_500 | ATR ZNF217 NCAPG2 PTPN3 BRCA1 MAP3K15 RAD54L HEATR1 CAPRIN2 EXO1 ATM TDRD12 | 2.00e-04 | 387 | 190 | 12 | gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_500 |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-NK_cells_L.1.3.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.11e-07 | 181 | 195 | 9 | e4dbc09f0210de465d8347969b301c22463a2b7d | |
| ToppCell | Control-immature_Neutrophil-|Control / Disease condition and Cell class | 1.28e-07 | 184 | 195 | 9 | c4e8ba82a6aa76c46f05a71d5f1c7926555318cf | |
| ToppCell | Control-immature_Neutrophil|Control / Disease condition and Cell class | 1.28e-07 | 184 | 195 | 9 | 2fdae5c6b3eb2232881d933a8c1061fda3623016 | |
| ToppCell | pdx-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.68e-07 | 190 | 195 | 9 | d06ee5f89f1cec8db6897fe3b2a890a07cd3697b | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.91e-07 | 193 | 195 | 9 | 4b9fa2a4424f8abe63fa7bee78db93dda04ab15f | |
| ToppCell | severe_influenza-T/NK_proliferative|World / disease group, cell group and cell class (v2) | 2.48e-07 | 199 | 195 | 9 | 1541f655f7d12c650added3683d07e5417a68dfb | |
| ToppCell | Sepsis-Int-URO-Lymphocyte-T/NK-T/NK_proliferative|Int-URO / Disease, condition lineage and cell class | 2.59e-07 | 200 | 195 | 9 | 99acc1ea01288efdd5b166aa20d66735f2bbe543 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.75e-07 | 157 | 195 | 8 | ec433d2fe827abdb647be4176c231b7052482b6f | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-FOXM1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.33e-06 | 180 | 195 | 8 | 334e2b1f6eb7d4ece20b1c7b02107863f913237f | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.57e-06 | 184 | 195 | 8 | 081d045f3bc98a36f342de7d50f39c9a888dd7eb | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.57e-06 | 184 | 195 | 8 | 84c20730cd92b9aaa50077d7b625e37e7f9e91d2 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.57e-06 | 184 | 195 | 8 | d31d4116d1d196633784863781fa45673607a421 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.57e-06 | 184 | 195 | 8 | a8c6028d745aaa6ee7842259238694cb50ce0526 | |
| ToppCell | Control-Myeloid_G-immature_Neutrophil|Control / Disease group, lineage and cell class | 1.57e-06 | 184 | 195 | 8 | 45f873236f7e90fb78c8e291d3b5b92d121acec9 | |
| ToppCell | droplet-Tongue-nan-24m-Epithelial-suprabasal|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-06 | 186 | 195 | 8 | 2913b5fd0617d024d600ba7015ec7b1961dade83 | |
| ToppCell | Control-Endothelial-Endothelial-FOXM1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.92e-06 | 189 | 195 | 8 | 1e1499b062d9c647c8f38b0c4e0d871d159be5dd | |
| ToppCell | Int-URO-Lymphocyte-T_NK-T_NK_proliferative|Int-URO / Disease, Lineage and Cell Type | 2.00e-06 | 190 | 195 | 8 | 005967c540418b85311308072a07c684f4296aef | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.42e-06 | 195 | 195 | 8 | 926eb3fc5d028be936885bea0654a77db3107234 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.42e-06 | 195 | 195 | 8 | 1a5e814e12fe37287dbfc58189e1958e2c76b5da | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.52e-06 | 196 | 195 | 8 | 1d2e0b328eb822db7521b5f5724d4bd17c0bad5f | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.61e-06 | 197 | 195 | 8 | 8b616cde333bdbc0c591035ad9e4949155866245 | |
| ToppCell | medial-Hematologic-Proliferating_Macrophage|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.71e-06 | 198 | 195 | 8 | da6963184c32761c896a9b91a5321ad84b583736 | |
| ToppCell | medial-2-Hematologic-Proliferating_Macrophage|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.71e-06 | 198 | 195 | 8 | 64a2bcf5a9ba66a4fe08fbde33f1886c136cde8f | |
| ToppCell | medial-Hematologic-Proliferating_Macrophage-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.71e-06 | 198 | 195 | 8 | fcc14ac3eb5088b9d6cd6af5a34dee5b81c0ece8 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-6_mon-Proliferating-Cycling_Progenitors|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 2.82e-06 | 199 | 195 | 8 | a99516a5760f49a69b0fe45a9b2316e393252966 | |
| ToppCell | Healthy_donor-T/NK_proliferative|World / disease group, cell group and cell class (v2) | 2.82e-06 | 199 | 195 | 8 | 1311dfd74b991f48b047a439f04f9bf7dfaa0e7a | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-FOXM1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.82e-06 | 199 | 195 | 8 | be2276c9a1994579ba1d2998b49bf549c1324d44 | |
| ToppCell | LPS_IL1RA-Epithelial_airway-airway_epithelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.92e-06 | 200 | 195 | 8 | cf191104484bfb2b9f87de416b9453135f8833c1 | |
| ToppCell | Control_saline-Endothelial-Endothelial-FOXM1|Control_saline / Treatment groups by lineage, cell group, cell type | 2.92e-06 | 200 | 195 | 8 | 9bbc7b5561151f6ff65f40b3226271def732e5d9 | |
| ToppCell | LPS_IL1RA-Epithelial_airway|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.92e-06 | 200 | 195 | 8 | a5ae33dd4dc1ff6e1a1eec22c4d523d5ab657607 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Proliferating-cycling_ventral_progenitors|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 2.92e-06 | 200 | 195 | 8 | 9359faa749f41aaef70b4874f20b4eed2dc12cc2 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.92e-06 | 200 | 195 | 8 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | Sepsis-URO-Lymphocyte-T/NK-T/NK_proliferative|URO / Disease, condition lineage and cell class | 2.92e-06 | 200 | 195 | 8 | f277db6cc288a52a5426120c1067608700ee8ccc | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Stem_cells-Neuroepithelial_cell|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 2.92e-06 | 200 | 195 | 8 | 0e119c2742f2be19fde8890d1227bf277ead976f | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Stem_cells|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 2.92e-06 | 200 | 195 | 8 | 008f137920cc3b599376706803c111d1d0ec17ef | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell-Treg_cell_2|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 5.35e-06 | 154 | 195 | 7 | 9200e2f1783e54cbc5dfc3b485b57c761af74a46 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-FOXM1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.76e-06 | 163 | 195 | 7 | 5285318c52aa31c9b22dc2ffff078e32e408604d | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-myeloid_dendritic_cell-Ccr7+_dendritic|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.41e-06 | 165 | 195 | 7 | c39f0479955c4e23921f7a450d3bc251a002200f | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.74e-06 | 166 | 195 | 7 | 2642544070564debe2deb2938d2c33997bf5ef02 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-FOXM1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.83e-06 | 169 | 195 | 7 | e0607af8ae8609d43e26ff2a2cab92650bfcd5b7 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling-Cycling_Distal_Convoluted_Tubule_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.83e-06 | 169 | 195 | 7 | e7514956b2e4298222ec443f98b2f5289451786e | |
| ToppCell | PND14-Immune-Immune_Myeloid-DC-cDC1-cDC1_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.19e-05 | 174 | 195 | 7 | 09b091e24317c3f7bac043f04762a533e30793de | |
| ToppCell | droplet-Lung-21m-Hematologic-Lymphocytic_NK_ILC-natural_killer_cell-proliferating_NK|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.23e-05 | 175 | 195 | 7 | 6751ee4b312d7f87275f2c35e5878cfc3be3ebe3 | |
| ToppCell | PND14-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.28e-05 | 176 | 195 | 7 | 450c25ec5eeb65425f904e0a25aaafdf5682ef9c | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.28e-05 | 176 | 195 | 7 | 3bbac5c2397535631fce8fa98f6ddb4fe0260351 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-05 | 178 | 195 | 7 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | 390C-Lymphocytic-NK_cells-Proliferating_NK_cell|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.43e-05 | 179 | 195 | 7 | e67ad7ab04d0c1309296f57c1f53c5ca14c213fe | |
| ToppCell | P15-Endothelial-proliferative_endothelial_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.53e-05 | 181 | 195 | 7 | 0c5bc1660b8fc1e905ab4230202862de5be46ebd | |
| ToppCell | droplet-Lung-3m-Hematologic-lymphocytic-Proliferating_T_cell-proliferating_T|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.53e-05 | 181 | 195 | 7 | 74311aac2fe27dc02a9be3bc20e0c7ef1c239049 | |
| ToppCell | P28-Endothelial-proliferative_endothelial_cell-proliferative_endothelial_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.53e-05 | 181 | 195 | 7 | e482fd116c00ff4d8db7be3c06b1bd1ffa2d479d | |
| ToppCell | P15-Endothelial-proliferative_endothelial_cell-proliferative_endothelial_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.53e-05 | 181 | 195 | 7 | f83565f09dd971c5cad2704a4a86bca0accd955e | |
| ToppCell | P28-Endothelial-proliferative_endothelial_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.53e-05 | 181 | 195 | 7 | 2be3d44619adb25d339e7a27b500a56e07e8de01 | |
| ToppCell | droplet-Lung-3m-Hematologic-lymphocytic-Proliferating_T_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.53e-05 | 181 | 195 | 7 | cf13bf7a531a2d40f8d778629cf2431b684f65f3 | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_9|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.63e-05 | 122 | 195 | 6 | 7dabf8b4c34a3714f45c3a99c1aa159e2d0b7e9c | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_9|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.63e-05 | 122 | 195 | 6 | 489a01c71882be5a6d71a19d06574698988c20f6 | |
| ToppCell | TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-5|TCGA-Liver / Sample_Type by Project: Shred V9 | 1.65e-05 | 183 | 195 | 7 | f604a8b62c7088fad8365dbf8d910fc980bd3ba8 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-classical_monocyte_proliferating|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.65e-05 | 183 | 195 | 7 | 6c1d7ce60e67bf1df364a4e177c351e7313eb41f | |
| ToppCell | Fetal_29-31_weeks-Immune-B_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.71e-05 | 184 | 195 | 7 | f4c9272d5cc4a70df051413b5c60ca6d1d80eb84 | |
| ToppCell | 3'-Distal_airway-Immune_Lymphocytic-Lymphocytic_T/NK-T_cell-T_cells_proliferating-T_cells_proliferating_L.1.1.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.71e-05 | 184 | 195 | 7 | eaef1dcde60ba14e2c7fd699d01c225487256d82 | |
| ToppCell | droplet-Lung-18m-Hematologic-lymphocytic-Proliferating_T_cell-proliferating_T|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.71e-05 | 184 | 195 | 7 | 1edefa2a049d7e22d0bdb1ea3d7ef1c8d6ae0fe3 | |
| ToppCell | droplet-Lung-18m-Hematologic-lymphocytic-Proliferating_T_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.71e-05 | 184 | 195 | 7 | 8578c50eaa8ce1cefc0228185c66c8e25f4bfc32 | |
| ToppCell | 3'-Distal_airway-Immune_Lymphocytic-Lymphocytic_T/NK-T_cell-T_cells_proliferating|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.71e-05 | 184 | 195 | 7 | bba0138c8f7e3645a688b9a4d12f6f2134ee2c08 | |
| ToppCell | 3'-Distal_airway-Immune_Lymphocytic-Lymphocytic_T/NK-T_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.71e-05 | 184 | 195 | 7 | fa73738350654066d7f9ebf78359e20ee6cbdd98 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_club|COVID-19 / group, cell type (main and fine annotations) | 1.77e-05 | 185 | 195 | 7 | cfe6fd73d817e173fe803bc1683c291d9bcb8608 | |
| ToppCell | Control-T_cells-Cycling_NK/T_cells|Control / group, cell type (main and fine annotations) | 1.77e-05 | 185 | 195 | 7 | 9766216b41ee62bbac4caa25cb98ec5627a24075 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-classical_monocyte_proliferating-classical_monocyte_proliferating_l33-52|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.77e-05 | 185 | 195 | 7 | 47c69500877b851c0c9744f5e1ef2ee0bff99168 | |
| ToppCell | facs-Lung-EPCAM-24m-Hematologic-Proliferating_Immune|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-05 | 186 | 195 | 7 | 9ce3bd121869215a4e6114a310f9d2fb5adaef61 | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 1.83e-05 | 186 | 195 | 7 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | facs-Lung-EPCAM-24m-Hematologic-leukocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-05 | 186 | 195 | 7 | a7fd35eabcfb534019dfe5a8a600bf2ec47c1ac2 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.83e-05 | 186 | 195 | 7 | acfa68a2afb7d2b51c9b469a1965fe5cc5d5e64e | |
| ToppCell | facs-Lung-EPCAM-24m-Hematologic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-05 | 186 | 195 | 7 | 18c40203463d4dd8558c04977d52e400a8268f90 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.96e-05 | 188 | 195 | 7 | 43a3a59f92ad93509d4166bd025aed0b1b39a008 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 1.96e-05 | 188 | 195 | 7 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | facs-MAT-Fat-3m-Lymphocytic-B_cell|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.96e-05 | 188 | 195 | 7 | a7158b5c94e6b356877f016e52f2c24a3f5d24d2 | |
| ToppCell | COVID-19-lung-Secretory|lung / Disease (COVID-19 only), tissue and cell type | 2.03e-05 | 189 | 195 | 7 | 84d48e3ed25bebb8bb8074b3a2c5e2e88cff7f25 | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-Proliferating_T_cell-proliferating_T|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.17e-05 | 191 | 195 | 7 | 15dbc5a03bfab8931c0fd385b0f25874736ae874 | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-Proliferating_T_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.17e-05 | 191 | 195 | 7 | 45c15f5ce4a207ac944bed65d45f06c1657d1a6d | |
| ToppCell | ASK454-Epithelial-Secretory|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.17e-05 | 191 | 195 | 7 | c63c781e7e93265e591cf494cb4ce8ed797c24fb | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 2.17e-05 | 191 | 195 | 7 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | droplet-Spleen-SPLEEN-30m-Lymphocytic-immature_NKT_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.17e-05 | 191 | 195 | 7 | c8b99bd3a30c81ee4deba9cbf0196920ab3ab550 | |
| ToppCell | control-Lymphoid-CTL|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.32e-05 | 193 | 195 | 7 | 89d407a88b5956559a589425b89b3eb8dc78e1dd | |
| ToppCell | droplet-Skin-nan-18m-Epithelial-epidermal_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.34e-05 | 130 | 195 | 6 | 4c8b931987432e8bcd39029d4fa124dc383ea355 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.40e-05 | 194 | 195 | 7 | f39a471293ecc5c5967b00e772b8f48ebc9affbe | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.40e-05 | 194 | 195 | 7 | 17af04acd54dd6a895a966cbb4422de25dc4f1e6 | |
| ToppCell | 3'_v3-Lung-Myeloid_Mac-Cycling_Myeloid-Mac|Lung / Manually curated celltypes from each tissue | 2.40e-05 | 194 | 195 | 7 | a8ae49157ca3f9e8b3f1750a995aee012dc859b6 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic-lymphocyte-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.40e-05 | 194 | 195 | 7 | 3c385d93c5fe1a7817813c492f79fdb94d887357 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.40e-05 | 194 | 195 | 7 | a75ecd0b0a928d4646602f7d16a645f6b3df3af5 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor2_(4)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.40e-05 | 194 | 195 | 7 | 6b286992d4bb56013c0ea5a7601d3476d806175a | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.40e-05 | 194 | 195 | 7 | 17744fd6645cf5a447a01a83f07e8d305c2bcd9c | |
| ToppCell | PBMC-Mild-Lymphocyte-B-Plasmablast-Plasmablast-Developping_Plasmablast|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.40e-05 | 194 | 195 | 7 | 5a519538327029ad2b880ef9647e2ac6ab3961a4 | |
| ToppCell | Bronchial-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasmablast|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.40e-05 | 194 | 195 | 7 | 81394fda763d3ff07f3f5ee2abd94ae0c73b6d39 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.40e-05 | 194 | 195 | 7 | e14f66f7584909621b776292fbd52808273fd2ee | |
| ToppCell | Control-Lymphoid_T/NK-T/NK_proliferative|Control / Disease group, lineage and cell class | 2.40e-05 | 194 | 195 | 7 | 9bbb124001fba7450f4639f47f9b720a483e7242 | |
| ToppCell | 3'-Distal_airway-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-NK_cells_L.1.3.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.40e-05 | 194 | 195 | 7 | 6cc689595a182fbf685fa2f3b9c300f7170fb81f | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic-lymphocyte|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.40e-05 | 194 | 195 | 7 | 635d0e88f9c542a1d9363066c6cdbc6e44db76c1 | |
| ToppCell | Dividing_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 2.48e-05 | 195 | 195 | 7 | 79ee423df85aa1631b7bdea74eacaf826dfc4a2c | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.48e-05 | 195 | 195 | 7 | b65463a804fed2d9a3be9e528ca8b9c98469bc86 | |
| ToppCell | Healthy/Control-T/NK_proliferative|Healthy/Control / Disease group and Cell class | 2.48e-05 | 195 | 195 | 7 | 957458fdc39723f4a31bd7fd3ce32891aa3fd462 | |
| ToppCell | 343B-Myeloid-Dendritic-cDC_proliferating_1|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.48e-05 | 195 | 195 | 7 | 47a01b8a92eebeb34ac7f70bf1ab4613a326e24f | |
| ToppCell | Dividing_cells-Dividing_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 2.48e-05 | 195 | 195 | 7 | 19829760dfcc0edafd2a2bd80f424a45d039af1f | |
| Drug | Sanguinarine [2447-54-3]; Down 200; 12uM; MCF7; HT_HG-U133A | NR2C1 VPS13C AGL ZBTB40 ATP13A3 VLDLR ANKFY1 UBR4 PEX26 ZNF75D ATM NNT | 9.01e-08 | 191 | 193 | 12 | 4168_DN |
| Drug | cobalt acetylacetonate | 2.38e-06 | 4 | 193 | 3 | CID000407383 | |
| Drug | Isoflupredone acetate [338-98-7]; Up 200; 9.6uM; PC3; HT_HG-U133A | PAN2 MAP3K9 ATP13A3 BCCIP HEATR1 PEX26 CSNK1A1 PRKCD ELF1 NNT | 4.90e-06 | 188 | 193 | 10 | 1832_UP |
| Drug | Paroxetine maleate [64006-44-6]; Down 200; 1uM; PC3; HT_HG-U133A | GGA2 ESRRA POLA2 STAT1 SEPTIN8 VPS13A ZBTB40 PEX26 CEP70 ATM | 7.41e-06 | 197 | 193 | 10 | 4556_DN |
| Drug | estradiol, USP; Up 200; 0.1uM; MCF7; HG-U133A | 7.41e-06 | 197 | 193 | 10 | 365_UP | |
| Drug | (-)-Cinchonidine [485-71-2]; Down 200; 13.6uM; HL60; HG-U133A | FOXK2 STAT1 IFIH1 ALDH3A2 DNAH3 ANKFY1 PEX26 PPP2R1B CD38 NNT | 7.41e-06 | 197 | 193 | 10 | 1780_DN |
| Disease | mean reticulocyte volume | FOXK2 ATR NUP210L STXBP4 ZNF217 KCNA4 VPS13A ZBTB40 MACIR PGS1 CLASP1 DNAH2 HPS3 PPP2R1B INTS4 ELF1 ATM HBE1 | 4.30e-06 | 799 | 189 | 18 | EFO_0010701 |
| Disease | Malignant neoplasm of breast | STXBP4 ESRRA CYP24A1 GDF10 PKDREJ STAT1 STAT3 BRCA1 PER2 OTOGL BTK MACIR RAD54L UBR4 HELQ EPG5 PPP1R3A EIF4A2 EXO1 ATM | 2.04e-05 | 1074 | 189 | 20 | C0006142 |
| Disease | ataxia telangiectasia (implicated_via_orthology) | 4.08e-05 | 2 | 189 | 2 | DOID:12704 (implicated_via_orthology) | |
| Disease | Adenocarcinoma of colon | 4.08e-05 | 2 | 189 | 2 | C0338106 | |
| Disease | Parkinson's disease 23 (implicated_via_orthology) | 4.08e-05 | 2 | 189 | 2 | DOID:0060896 (implicated_via_orthology) | |
| Disease | choreaacanthocytosis (implicated_via_orthology) | 4.08e-05 | 2 | 189 | 2 | DOID:0050766 (implicated_via_orthology) | |
| Disease | eosinophil count | ATR SIPA1L3 STAT1 ZNF585B IFIH1 SEPTIN8 SLC9C1 CILP2 CLC BRCA1 XRN1 ZBTB40 DNAH3 FPR1 NR3C1 DNAH7 PPP1R3A CD28 TMED8 EXO1 ELF1 ATM NNT | 8.65e-05 | 1488 | 189 | 23 | EFO_0004842 |
| Disease | autosomal recessive spinocerebellar ataxia 4 (implicated_via_orthology) | 1.22e-04 | 3 | 189 | 2 | DOID:0111611 (implicated_via_orthology) | |
| Disease | chromosome 15q11.2 deletion syndrome (implicated_via_orthology) | 1.22e-04 | 3 | 189 | 2 | DOID:0060393 (implicated_via_orthology) | |
| Disease | Cohen syndrome (implicated_via_orthology) | 1.22e-04 | 3 | 189 | 2 | DOID:0111590 (implicated_via_orthology) | |
| Disease | duodenal ulcer (implicated_via_orthology) | 1.22e-04 | 3 | 189 | 2 | DOID:1724 (implicated_via_orthology) | |
| Disease | Episodic Ataxia | 2.43e-04 | 4 | 189 | 2 | C1720189 | |
| Disease | BREAST CANCER | 3.16e-04 | 21 | 189 | 3 | 114480 | |
| Disease | angiomyolipoma (is_marker_for) | 4.03e-04 | 5 | 189 | 2 | DOID:3314 (is_marker_for) | |
| Disease | vascular endothelial growth factor measurement | 4.62e-04 | 56 | 189 | 4 | EFO_0004762 | |
| Disease | breast cancer (implicated_via_orthology) | 5.36e-04 | 25 | 189 | 3 | DOID:1612 (implicated_via_orthology) | |
| Disease | triglyceride measurement, very low density lipoprotein cholesterol measurement | 6.29e-04 | 224 | 189 | 7 | EFO_0004530, EFO_0008317 | |
| Disease | triglycerides in small VLDL measurement | 6.40e-04 | 61 | 189 | 4 | EFO_0022145 | |
| Disease | Malignant tumor of breast | 6.75e-04 | 27 | 189 | 3 | cv:C0006142 | |
| Disease | Breast neoplasm | 6.75e-04 | 27 | 189 | 3 | cv:C1458155 | |
| Disease | Familial cancer of breast | 6.75e-04 | 27 | 189 | 3 | cv:C0346153 | |
| Disease | systemic lupus erythematosus | PLEKHM1 STAT1 ACOX2 STAT3 MYO5C TYK2 IFIH1 MACIR PGS1 RALGPS2 WDFY4 CD28 ELF1 TNPO3 | 6.76e-04 | 799 | 189 | 14 | MONDO_0007915 |
| Disease | Breast Carcinoma | STXBP4 ESRRA CYP24A1 GDF10 STAT3 BRCA1 BTK MACIR RAD54L EXO1 ATM | 7.45e-04 | 538 | 189 | 11 | C0678222 |
| Disease | age at menopause | 7.72e-04 | 302 | 189 | 8 | EFO_0004704 | |
| Disease | C-reactive protein measurement | TDRD15 NUP210L VPS13C FNBP1L STAT3 PTPN3 CILP2 SCN4A ZBTB40 GCN1 DAGLA DMGDH MMS22L PGS1 COX6A1 CYFIP2 PCCB TNPO3 | 7.88e-04 | 1206 | 189 | 18 | EFO_0004458 |
| Disease | mean corpuscular hemoglobin concentration | FOXK2 ATR STXBP4 ZNF217 BTBD9 STAT3 KCNA4 VPS13A MACIR PGS1 CLASP1 ARID4A BCCIP EXO1 ELF1 ZDHHC19 HBE1 | 7.93e-04 | 1105 | 189 | 17 | EFO_0004528 |
| Disease | disease of cellular proliferation (implicated_via_orthology) | 8.39e-04 | 7 | 189 | 2 | DOID:14566 (implicated_via_orthology) | |
| Disease | Breast Cancer, Familial | 9.24e-04 | 30 | 189 | 3 | C0346153 | |
| Disease | Adult T-Cell Lymphoma/Leukemia | 1.02e-03 | 31 | 189 | 3 | C0023493 | |
| Disease | cerebellar ataxia (implicated_via_orthology) | 1.11e-03 | 8 | 189 | 2 | DOID:0050753 (implicated_via_orthology) | |
| Disease | vitamin D measurement, vitamin D dietary intake measurement | 1.11e-03 | 8 | 189 | 2 | EFO_0004631, EFO_0008539 | |
| Disease | Alcoholic Intoxication | 1.12e-03 | 32 | 189 | 3 | C0001969 | |
| Disease | reticulocyte measurement | FOXK2 ATR ZNF217 STAT1 KCNA4 VPS13A ZBTB40 MACIR PGS1 DNAH10 CLASP1 ECPAS SLC9A5 RORB ZDHHC19 HBE1 | 1.28e-03 | 1053 | 189 | 16 | EFO_0010700 |
| Disease | COVID-19 symptoms measurement | 1.46e-03 | 35 | 189 | 3 | EFO_0600019 | |
| Disease | vitamin D measurement | 1.52e-03 | 336 | 189 | 8 | EFO_0004631 | |
| Disease | colon cancer (is_implicated_in) | 1.58e-03 | 36 | 189 | 3 | DOID:219 (is_implicated_in) | |
| Disease | non-alcoholic fatty liver disease (implicated_via_orthology) | 1.58e-03 | 36 | 189 | 3 | DOID:0080208 (implicated_via_orthology) | |
| Disease | Metabolic Diseases | 1.78e-03 | 10 | 189 | 2 | C0025517 | |
| Disease | postburn hypertrophic scarring severity measurement | 1.78e-03 | 10 | 189 | 2 | EFO_0007747 | |
| Disease | Peripheral T-Cell Lymphoma | 1.78e-03 | 10 | 189 | 2 | C0079774 | |
| Disease | Otitis media | 1.99e-03 | 39 | 189 | 3 | EFO_0004992 | |
| Disease | fatty acid measurement | 2.09e-03 | 436 | 189 | 9 | EFO_0005110 | |
| Disease | Inherited neuropathies | 2.15e-03 | 40 | 189 | 3 | C0598589 | |
| Disease | ovarian carcinoma, COVID-19 | 2.16e-03 | 11 | 189 | 2 | EFO_0001075, MONDO_0100096 | |
| Disease | Mammary Carcinoma, Human | STXBP4 ESRRA CYP24A1 GDF10 STAT3 BRCA1 MACIR RAD54L EXO1 ATM | 2.16e-03 | 525 | 189 | 10 | C4704874 |
| Disease | Mammary Neoplasms, Human | STXBP4 ESRRA CYP24A1 GDF10 STAT3 BRCA1 MACIR RAD54L EXO1 ATM | 2.16e-03 | 525 | 189 | 10 | C1257931 |
| Disease | Mammary Neoplasms | STXBP4 ESRRA CYP24A1 GDF10 STAT3 BRCA1 MACIR RAD54L EXO1 ATM | 2.22e-03 | 527 | 189 | 10 | C1458155 |
| Disease | non-high density lipoprotein cholesterol measurement | TDRD15 STAT3 TYK2 PTPN3 KCNA4 XRN1 VLDLR PGS1 DNAH10 COX6A1 E2F3 PCCB | 2.27e-03 | 713 | 189 | 12 | EFO_0005689 |
| Disease | alkaline phosphatase measurement | TDRD15 CYP24A1 FNBP1L PLEKHM1 CILP2 ZBTB40 TAT TMEM50B SUPT3H PGS1 C6orf62 WNT3 COX6A1 ELF1 PCCB | 2.37e-03 | 1015 | 189 | 15 | EFO_0004533 |
| Disease | lymphangioleiomyomatosis (is_marker_for) | 2.58e-03 | 12 | 189 | 2 | DOID:3319 (is_marker_for) | |
| Disease | acute myeloid leukemia (implicated_via_orthology) | 2.58e-03 | 12 | 189 | 2 | DOID:9119 (implicated_via_orthology) | |
| Disease | nasopharynx carcinoma (is_marker_for) | 2.64e-03 | 43 | 189 | 3 | DOID:9261 (is_marker_for) | |
| Disease | obesity (implicated_via_orthology) | 2.70e-03 | 215 | 189 | 6 | DOID:9970 (implicated_via_orthology) | |
| Disease | lymphocyte count | ACACA ZNF217 TYK2 IFIH1 CILP2 SERPINB6 PSME4 SYT11 MACIR SUPT3H MMS22L DNAH10 FPR1 POLR2E E2F3 CD28 CD38 ELF1 ATM | 2.81e-03 | 1464 | 189 | 19 | EFO_0004587 |
| Disease | triglycerides:total lipids ratio, low density lipoprotein cholesterol measurement | 2.86e-03 | 150 | 189 | 5 | EFO_0004611, EFO_0020947 | |
| Disease | smoking status measurement, ulcerative colitis | 3.04e-03 | 13 | 189 | 2 | EFO_0000729, EFO_0006527 | |
| Disease | platelet crit | MYO1E NUP210L STXBP4 NCAPG2 TYK2 SERPINB6 KCNA4 VLDLR DNAH3 PGS1 POLR2H EPG5 ELF1 TNPO3 | 3.43e-03 | 952 | 189 | 14 | EFO_0007985 |
| Disease | colorectal cancer (is_marker_for) | 3.48e-03 | 157 | 189 | 5 | DOID:9256 (is_marker_for) | |
| Disease | triglyceride measurement, low density lipoprotein cholesterol measurement | 4.41e-03 | 166 | 189 | 5 | EFO_0004530, EFO_0004611 | |
| Disease | red blood cell density measurement | ATR ACO1 STXBP4 ZNF217 FNBP1L PTPN3 KCNA4 ZBTB40 MACIR VLDLR DNAH10 DNAH2 ZDHHC19 | 4.57e-03 | 880 | 189 | 13 | EFO_0007978 |
| Disease | Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse | 4.62e-03 | 16 | 189 | 2 | C0334634 | |
| Disease | lung non-small cell carcinoma (is_marker_for) | 4.75e-03 | 169 | 189 | 5 | DOID:3908 (is_marker_for) | |
| Disease | forced expiratory volume | PLEKHM1 FIG4 AGL SCN4A ZBTB40 MTCH2 DMGDH SUPT3H WNT3 RALGPS2 CYFIP2 NNT | 5.08e-03 | 789 | 189 | 12 | EFO_0004314 |
| Disease | Benign neoplasm of stomach | 5.21e-03 | 17 | 189 | 2 | C0153943 | |
| Disease | Neoplasm of uncertain or unknown behavior of stomach | 5.21e-03 | 17 | 189 | 2 | C0496905 | |
| Disease | pre-malignant neoplasm (biomarker_via_orthology) | 5.21e-03 | 17 | 189 | 2 | DOID:0060071 (biomarker_via_orthology) | |
| Disease | cyclic adenosine monophosphate measurement | 5.21e-03 | 17 | 189 | 2 | EFO_0010473 | |
| Disease | Carcinoma in situ of stomach | 5.21e-03 | 17 | 189 | 2 | C0154060 | |
| Disease | non-Hodgkin lymphoma (is_implicated_in) | 5.21e-03 | 17 | 189 | 2 | DOID:0060060 (is_implicated_in) | |
| Disease | ulcerative colitis (is_implicated_in) | 5.21e-03 | 17 | 189 | 2 | DOID:8577 (is_implicated_in) | |
| Disease | leukemia | 5.31e-03 | 55 | 189 | 3 | C0023418 | |
| Disease | hematocrit | TDRD15 ACACA ACO1 KCNA4 ZBTB40 VLDLR SUPT3H ANKFY1 WNT3 DNAH2 PRXL2A NR3C1 HBE1 TDRD12 | 5.78e-03 | 1011 | 189 | 14 | EFO_0004348 |
| Disease | Psoriasis | 5.87e-03 | 57 | 189 | 3 | C0033860 | |
| Disease | Pustulosis of Palms and Soles | 5.87e-03 | 57 | 189 | 3 | C0030246 | |
| Disease | pancreatic cancer (is_implicated_in) | 5.92e-03 | 112 | 189 | 4 | DOID:1793 (is_implicated_in) | |
| Disease | vital capacity | MYO1E PLEKHM1 ZBTB40 PAN2 DAGLA MTCH2 SUPT3H MMS22L WNT3 RALGPS2 PCDHA12 NR3C1 CAPRIN2 MYO1F AP5M1 NNT | 6.14e-03 | 1236 | 189 | 16 | EFO_0004312 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YQPVAQRMTVVVLKA | 301 | Q9BT88 | |
| IQAVERQYVIPGMFK | 596 | P21399 | |
| ETIIMNQILPYIKEL | 331 | P30154 | |
| KDVGELYMKPLQQTV | 246 | Q68DN1 | |
| LDGELLDTMPKQYVN | 1561 | Q9HCE0 | |
| VKLGTAQSNYLPMVV | 281 | Q99424 | |
| ILQLLQMEQPGEYIS | 216 | Q12834 | |
| MIQIKELASYNPIVL | 476 | Q9Y6F8 | |
| IPVMTNNYEENILKG | 56 | Q9GZU0 | |
| GIPEVMETQQVQEKY | 146 | P32519 | |
| YMLVVGNIVIKPASQ | 276 | O42043 | |
| YMLVVGNIVIKPDSQ | 386 | Q9UKH3 | |
| KQIYMDLGIPILNSA | 366 | P29374 | |
| MKQLVEPILGAAVYN | 996 | Q9H7T0 | |
| ILVKQSPMLVAYDNA | 21 | P10747 | |
| EVIPVTLAMENTYQK | 1706 | Q68DQ2 | |
| KQRPIFIITEYMANG | 466 | Q06187 | |
| YLMTGNVVASIQKLP | 696 | O60242 | |
| IMLYPVASVDQVLQI | 1121 | Q9H7F0 | |
| GEQNMVLFAPIIYVL | 971 | A8K2U0 | |
| QLQIAMGIPLYRIKD | 461 | Q13085 | |
| KNVLTMLDEAYIQPQ | 86 | P51648 | |
| MDNYQEILKVPLALQ | 386 | Q8WUY9 | |
| IILSKMQDIPIYANV | 66 | Q8WZ64 | |
| KGVLMAGLYPNLIQV | 1016 | Q7L2E3 | |
| TLKYVLMNAGEPLNE | 131 | Q8TD86 | |
| LKQGQYSPMAIEEQV | 471 | P25705 | |
| ITEEDYQPLMKLGTQ | 101 | P28907 | |
| LMYVKVLIQVGYEPL | 21 | Q9Y6C9 | |
| MNYIQVTPQEKEAIE | 311 | P54725 | |
| QYLLIQGVPAVGVMK | 46 | Q5RL73 | |
| ILKMEPADYNSQIIG | 586 | P13056 | |
| EPQLSGKMLVLDYIL | 491 | Q92698 | |
| VKVQVLYPDGQAQMI | 861 | Q96HW7 | |
| VNMEIPAANLVNKYI | 701 | P26045 | |
| DVIKLQINMYTTPVL | 201 | Q8NHS3 | |
| LYLIEMDSQLPGKLN | 236 | Q9P2R3 | |
| LGYQGIAVVMEELLK | 921 | Q7L576 | |
| INLMVPKDQVLDTVY | 1091 | Q504Q3 | |
| RMVVLQPLDEYNLGK | 801 | A0AUZ9 | |
| KNIMNFIDIVAIIPY | 251 | Q09470 | |
| LQGIALKYGVTMEQI | 81 | Q8IV50 | |
| AESMGIEVKLYNLLP | 176 | P17735 | |
| KNGIQNMLQFYIPEV | 221 | Q9UMS0 | |
| YLTTDKEVPGLVLMQ | 211 | Q3T906 | |
| PENFKLLGNVMVIIL | 101 | P02100 | |
| MQYPIVIKNTKGEEI | 236 | Q9H9P8 | |
| ISKMGYLDPRNEQIV | 136 | Q9NRM7 | |
| LDLQPQAKVLMSVQY | 106 | Q05655 | |
| ITMAPDKQLTLNGIY | 271 | Q01167 | |
| VLQMYIKNLSGPDDL | 821 | Q6ZRQ5 | |
| IALPMYQQLQKELAG | 191 | Q9P287 | |
| LDENRNVVLKVYPNM | 456 | P55107 | |
| GLQKVEMENQIYAIP | 101 | P52789 | |
| MEALVASYLIKPEVQ | 481 | Q5VYK3 | |
| MTPYLVKVRDQQGAE | 291 | O15055 | |
| PVRQAGVIYLKNMIT | 51 | O95373 | |
| MIKEPADTEVLQYQL | 176 | Q96GV9 | |
| IYPLIQMKPFEIQID | 351 | Q32NB8 | |
| LLYSKMQEPGAVLDV | 126 | Q7Z412 | |
| QKYTQNDLMIDPLIV | 846 | Q9H0H0 | |
| PLYEDIMSLLIQIGQ | 1116 | Q9H0H0 | |
| LYAVTKLPQITEIGM | 506 | Q6UY01 | |
| LSISVLPDKYQVMVN | 91 | Q05315 | |
| ADLKNGALVVYEMVP | 116 | Q8IVB5 | |
| DLLTQGVLLYKQVME | 301 | Q9UJY4 | |
| EMLAEIITNQIPKYS | 751 | P04150 | |
| MQTPAGELYDKSIIQ | 766 | Q92616 | |
| LKGQMIYLPEADSIL | 306 | Q02153 | |
| PILGFYQMKEEEVQL | 321 | Q9H0R1 | |
| GYQGIAVVMEELLKI | 946 | Q96F07 | |
| ALPGVAVSMLNVYLK | 46 | P12074 | |
| MLGEEVQLYFIIPKS | 1471 | Q9C091 | |
| QLMGESDPDLLVQKY | 276 | Q96M63 | |
| NIKILDVNDNIPYME | 256 | Q02413 | |
| IQQQVSKYPLMEEIG | 161 | Q8NFU5 | |
| ANYVVQKMIDVAEPG | 1121 | Q14671 | |
| EYSVEKSLGPMILIN | 1001 | Q16821 | |
| EIMPNYAKNIIVGFA | 331 | P05166 | |
| NAMLRLGVLQPEVYK | 1081 | P38398 | |
| ARKVIVELMAYENPN | 471 | Q9YNA8 | |
| RKVIVELMAYENANP | 471 | Q9HDB9 | |
| VVNMAQKAIIRYFPV | 121 | O15217 | |
| ENPAVIMQTYLEKAV | 2351 | Q13315 | |
| MEIIAKVFLAYPQQA | 2161 | Q13535 | |
| GMKLAANRIYEILPQ | 396 | Q9P0U4 | |
| ALYQLVAKPMQALEV | 781 | Q14674 | |
| MTQEYDNKRPVLVLQ | 1 | Q9NZI5 | |
| MRKGIQPALEQYLVT | 1 | O00716 | |
| VVIPQIYKQLQEMDE | 206 | Q5T0N5 | |
| MQVLGPEDLQSIIYK | 541 | Q8NHQ1 | |
| EYALPKGTVLMLNTQ | 406 | Q07973 | |
| VEYKIINPKAITMGQ | 1741 | Q8TD57 | |
| YMLVVGNIVIKPDSQ | 276 | P61566 | |
| YMLVVGNIVIKPDSQ | 276 | P61567 | |
| QLLVNPMNIYEEQKI | 66 | Q5T197 | |
| TENVVQPMKELYGIN | 791 | Q92562 | |
| MALYPNIQGQVQKEI | 326 | Q6VVX0 | |
| ELQPYFQTLPVMTKI | 216 | P17213 | |
| QTAIPMGIKALEQYL | 1196 | Q8WXX0 | |
| YQMEVAQPALEGKNI | 311 | Q9BYX4 | |
| YAGQMKEPIQLEITE | 406 | Q9Y2G2 | |
| MQLQADILYIPVVKP | 441 | P32189 | |
| STYMQIVKLLGLDVP | 151 | Q9HAW0 | |
| VNVPLYVNLMKNEEV | 1056 | Q6IMN6 | |
| YMLVVGNIVIKPDSQ | 386 | P61565 | |
| QIQKVILALGDYMGA | 116 | Q14240 | |
| EPVGSEYKQVMQRVA | 516 | Q9UI17 | |
| LPYVVMEGLNKVLEN | 651 | Q9Y4D2 | |
| INLPDMDKYGTQRVI | 2666 | Q14204 | |
| QLPLKVVEMYNIDEG | 91 | Q8IYD2 | |
| EKLIVVNQNMQPLYV | 3076 | Q03164 | |
| MVQNIIYEKLDSSVP | 401 | O60383 | |
| YAGMPTIQITALEKI | 1096 | Q9H583 | |
| YIMDNKLAQIEGVVP | 121 | Q14527 | |
| VYAEMINNLLGPLVE | 1341 | Q49AJ0 | |
| MILPYVAIVQEKISG | 386 | Q8TDG4 | |
| INKNYLEIPVEQLML | 51 | Q8IXS0 | |
| LIPEENIATMKYGAQ | 271 | Q96Q07 | |
| QMIDKYINEANLIPE | 2046 | Q9C0D2 | |
| YAVLPIQVDKVVQMF | 2086 | Q8IVF4 | |
| VKQKIPEMIDYEGTQ | 4161 | Q9P225 | |
| MSSQVVGIEPLYIKA | 1 | P11474 | |
| AVAYGVAMNKLALPI | 356 | P80192 | |
| VSVLNPGQSMIKYLE | 2121 | Q3ZCN5 | |
| GQIIEIPIAMYHINK | 561 | Q5VU65 | |
| PYTNVSVKLILMNPE | 451 | P28827 | |
| GFLVQIMKYAEQRIP | 266 | Q2NL67 | |
| PITGDMQLVKYLNFE | 296 | Q9Y5E6 | |
| YEIQVNAIDKGIPSM | 316 | Q9UN75 | |
| PMDLAVALGYRKVQQ | 226 | O14593 | |
| LKVTPEEYAGQITLM | 46 | Q86X27 | |
| VSENGYIKIFMEQVP | 716 | Q6ZN16 | |
| QYPIADLVKMLTEQG | 941 | Q13423 | |
| LLQYLVAIPMEKGLD | 811 | Q9Y4G2 | |
| VSVPYAMNLLNGIKL | 61 | Q9Y580 | |
| LVDPDMIKAINQGNY | 141 | Q9GZM7 | |
| IKVPVMYLDDVTQSQ | 151 | Q8TBZ9 | |
| DIIRNYKVMAAENIP | 646 | P42224 | |
| MAPKYILEQFLQQEL | 121 | P19388 | |
| PRPQNKIQGMVYDLV | 1336 | P35499 | |
| IEKAITLENPYMLNE | 471 | Q4G0N8 | |
| LENKIGVLQNMRVPY | 161 | P48775 | |
| QVKGYVQAILPLQMF | 151 | B5MCY1 | |
| VNTISPVQLYKEMVD | 491 | Q969F9 | |
| KNIRVVVESFMQLPY | 106 | Q587J7 | |
| YIVASVLNNMKTELP | 711 | Q9NTG1 | |
| LLQGMYKEIGIAVDV | 271 | P21462 | |
| QEKDYNVLVMDLLGP | 81 | P48729 | |
| TQILVLPYVGKELNM | 216 | P35237 | |
| PLDLTGKVYQLEVML | 1711 | O60292 | |
| LVPLDKIDQVVMSYG | 391 | Q14940 | |
| LLLSMVPVIYQKNQE | 41 | Q96JW4 | |
| LKEYSLFPGQVVIME | 291 | Q14181 | |
| GQLEVPEEQMGQLKY | 271 | P07476 | |
| VKEPQMQVLELPYVN | 226 | Q96P15 | |
| EMALNYLGIQPTKEQ | 221 | Q6ZWJ1 | |
| LKMNITVPEDYINGF | 261 | Q9UQ84 | |
| MLDQLGVPLYAVVKE | 101 | Q9BRX8 | |
| YNLETILPKMGIQNV | 316 | Q86WD7 | |
| MTQGDPAKQLYEELV | 486 | A6NHY2 | |
| LKVKIQGPQEYMVRS | 941 | Q8IUL8 | |
| LQGLQKSLMVYIAEI | 251 | Q86XI2 | |
| IQTADYPINLAAIKM | 1431 | Q7Z460 | |
| VYLQKENIIDESGMP | 66 | A0A087X0M5 | |
| LMEVYKNTPETVNLI | 841 | Q9C0E2 | |
| QAIKQMYVLILGLDV | 2851 | Q96RL7 | |
| IKPNVVAMEILAYLA | 211 | O75486 | |
| MIQKLYLQPGALLEQ | 1106 | Q99973 | |
| PLPKNMAEQIIQEIY | 261 | P29401 | |
| GYKIMDATNILVSPL | 656 | P40763 | |
| VQLIPILVNGMKYSE | 296 | O14787 | |
| LLGPLEKTLYNDVMQ | 221 | Q92670 | |
| LDMTGIKQIKQEPIY | 181 | Q92753 | |
| LMGLQPATEYIVNLV | 831 | Q92752 | |
| QVIGSAKMLYIQALP | 1186 | Q6ZS81 | |
| SYLPVQLLASGMKEV | 106 | Q9NVV0 | |
| LAVAKIIIIEFNPMY | 271 | Q9NRS4 | |
| MIDAAVVYPKPEQLN | 41 | P56557 | |
| MQYFQPTIQEKGAVL | 1246 | Q8IZH2 | |
| VGYQVPKPEVVMLEQ | 66 | Q52M93 | |
| NYIEIMPSVAEGVKL | 61 | P56703 | |
| IKIMGELVSNGVQIY | 201 | Q92599 | |
| ISGEIMELVLVKYQG | 2706 | Q709C8 | |
| KQMYVLVLGLDVLGN | 3411 | Q709C8 | |
| KMDLILDVNIQIYPV | 36 | P52434 | |
| LQPVVKQVLYLLGAM | 316 | A6NDV4 | |
| KNMVVYAGVEEQPKL | 1281 | Q14997 | |
| MEGAKPTLQLVYQAV | 1 | Q9Y5L0 | |
| LLNPLEKTLYNDVMQ | 251 | P51815 | |
| GPKYMAEAVQLQRVV | 256 | Q8WVZ1 | |
| TQEKNVIQIEGYMPL | 51 | O75362 | |
| TNKENLPVVILYAEM | 176 | Q9NYU1 | |
| PMLLELAKQDVVLNY | 956 | Q15029 | |
| PYLSFGEVEKMQILV | 4621 | Q5T4S7 | |
| LIEYVKQNIDNLMTP | 911 | Q69YN4 | |
| AKYQVPQRSGDIVMI | 111 | Q6PL24 | |
| GLQPVMQELAYIGVL | 656 | Q9NUA8 | |
| EKSLQLVMEYVPLGS | 971 | P29597 | |
| VKMIDNVYNPAAIAV | 506 | P98155 | |
| IQDYCKMVPNGLDIL | 1161 | P35573 | |
| KNIMNIIDIVSILPY | 401 | P22459 | |
| YIGSVLISVNPFKQM | 51 | Q12965 | |
| RAMQKPQEEYSIGVL | 371 | O00160 | |
| KNIQPIIVPGMLEYE | 1506 | Q9NQX4 |